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GENERAL INTRODUCTION 
Bovine tuberculosis is caused by Mycobacterium bovis which is a 
member of the M. tuberculosis complex that includes M. tuberculosis, M. 
microti, and M. africanum. Disease usually includes a progressive 
granulomatous lesion of the thoracic cavity with possible involvement 
of other organs of the body often resulting in death. Following 
inhalation, the organism is ingested by macrophages which fail to 
destroy the organism. Death of the macrophage stimulates T-lymphocytes 
involved in cell mediated irrununity (CMI) followed by localization of T-
cells and granulocytes, tissue destruction, and mineralization and 
caseous nodule formation. Mycobacterium bovis infection in cattle has 
been almost eliminated due to eradication programs but it continues to 
be a problem in domestic animals in developing countries and in captive 
exotic animals. Bovine tuberculosis is a serious problem in animals in 
zoological parks and primate colonies where M. bovis has been detected 
with increased frequency from exotic ruminants and from non-human 
primates. Due to the high monetary and aesthetic value of these 
animals eradication of infected animals is not an acceptable approach. 
Alternative control possibilities could include early detection of 
disease and subsequent treatment. 
Currently, effective vaccines do not exist and the diagnostic 
efficacy of tuberculin skin tests has been limited due to lack of 
highly specific diagnostic antigens. Antigens obtained by classical 
2 
biochemical methods are complex and contain non-specific determinants . 
Since CM! is important in controlling bovine tuberculosis, antigens 
involved in T-cell proliferation could be important in diagnosis where 
delayed type hypersensitivity (DTH) develops. Exposure of T-cells to 
antigens specific for stimulation could prime i1TUTiune responses for 
future exposure to .!:!· bovis and pr ovide additional host resistance t o 
disease. Methods t o survey antigens from !!· bovis would facilitate 
identification of specific serodiagnostic determinants and/or possible 
antigens that stimulate T-cell response . 
Hybridoma technol ogy and monoclonal antibody (McAb) production is 
an approach that allows identification of antigenic determinants of M. 
bovis. Monoclonal antibodies with binding activity to determinants 
specific for M. bovis, and that compete with and inhibit binding of 
serum antibody, could be used in serodiagnostic enzyme-linked 
i1TUTiunosorbent assays (ELISA) . In addition, corresponding antigen could 
be isolated through McAb linked affinity chromatography and used in 
combination with the McAb in ELISA or alone as a skin test antigen . 
I1TUTiunologic reagents with improved specificity could minimize problems 
associated with cross-reactivity in assays used to evaluate imnune 
responses. Monoclonal antibodies could also be used as t ool s to detect 
gene products of an expression library that may be associated with 
humeral and cell mediated responses or to detect mycobacterial 
components in animal tissue. Al ternatively, McAb that detect cr oss-
reactive determinants could be used t o identify and possibly r emove 
3 
cross reactive components in antigenic preparations. Monocl onal 
antibodies also have taxonomic and epidemiological applications 
involving strain identification of field isolates. 
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LITERA'IURE REVIEW 
Monoclonal antibodies (McAb) have been produced to investigate the 
antigenic composition of mycobacteria. Available information indicates 
that organisms used for irrununization and hybridoma production have 
included M. tuberculosis, 117111112117125132133 M. leprae, 3114116 
19,24,25,44 1 . 2 bo . BCG 3,25,28,29,34 a fi'eld M. epraemur1um, M. vis , 
isolate of M. bovis, 29 and M. avium-M. intracellulare-M. scrofulaceum 
(MAIS) complex serovars 4, 8, and 9. 30 The initial objective of 
producing McAb to M. tuberculosis was to differentiate between strains 
of M. tuberculosis and of M. bovis. 7 Another objective was to use McAb 
to isolate antigens of M. tuberculosis by immunosorbent affinity 
chromatography and to study antigen specificity for use in skin-tests 
and/or serodiagnosis of tuberculosis. 12132 Subsequent objectives were 
to provide a tool for identification of ~· tuberculosis antigen in 
d . . 1,25,33 . h . 1 h . . f sero iagnos1s or immunoc em1ca c aracter1zat1on o M. 
tuberculosis antigen, 1133 to identify shared antigens among 
mycobacteria, 11 and to detect and isolate peptide antigens expressed in 
DNA cloning experiments. 17 Similarly, the objectives of producing McAb 
to M. bovis BCG have been to develop a tool for identification of M. 
bovis BCG antigen in serodiagnosis, 25 to isolate antigen by 
immunosorbent affinity chromatography for partial characterization, 28 
to detect antigen in sonicated extracts of M. bovis that do not occur 
in related species, 29 to detect cross-reactive determinants, 3 o~ to 
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detect cell wall and Band C glycolipids . 34 In general, McAb have been 
used for detection and physical isolation of antigenic comp:::>nents . 
Various mycobacterial species and corresp:::>nding antigen 
preparations have been utilized t o establish hybridoma cell lines that 
produce murine McAb (Table 1). Mycobacterium bovis sa; antigen 
preparations contained dry weight sonicated whole cells (SWC) , 25 
sonicated heat killed whole cells (SHKW:), 28 and sonicate supernatant 
(SON lS) obtained by sonicat i ng cells that were gr own on Lowenstein-
Jensen medium26 plus sodium pyruvat e followed by centrifugation at 1000 
x g for 20 minutes at 4°c . 29 138 For one immunization schedule, SON lS 
from M. bovis (field isolate 117/79) was utilized. 29138 Similarly, 
lyophilized whole cells were resuspended, ultrasonicated, and 
centrifuged at 20 ,000 x g for 15 minutes t o prepare soluble sonicate 
antigen (SON 20S) . 3 Al so , cell walls have been extracted from M. bovis 
Ba; for use in immunization. 34 
Mycobacterium tuberculosis H37Rv has been used to prepar e 
pr essate antigen (PRES lOOS) obtained by passing harvested organisms 
through a bacterial press followed by centrifugation at 100 ,000 x g . 7 
Other M. tuberculosis antigen preparations included intact whole cells 
(WC), 25 dry weight swc, 25 whole cells autoclaved at l 00°c (HKWC) and 
dried at 37°c ,17 supernatant obtai ned after sonication and 
centrifugation at 60 ,000 x g (SON 605) ,5 16 bacterial press extract 
(BPE) obtained after r upturing cells i n a Frenc h press at 14,000 lb/ in2 
with rerroval of insoluble material by centrifugation at 40 ,000 x g 
TABLE 1. List of rronoclonal antibodies produced for various mycobacterial species 
including culture media and antigen preparations used in immunization . 
Immunization Schedule 
Organism Antigenb (arrount) Day 
c,d Route Monoclonal Reference 
M. bovis BCG 
M. bovis BCG (Glaxo) 
M. bovis BCG (Glaxo) 
M. bovis 117/79# 
M. bovis BCG 
M. bovis BCG 
Sau ton swc (100 ug) 
" 
" 
SWC (500 ug) 
SHKWC (1 mg) 
" 
" 
Lowenstein- SON lS (50 ug) 
Jensen " 
( 4-6 wks.) 
Lowenstein- SON lS (50 ug) 
Jensen 
(4-6 wks.) 
" 
SON 20S (50 ug) + ? 
" 
" 
cell wall (?) 
0 
30 
341 
362 
0 
21 
3 d.p.f. 
0 
21 
0 
21 
0 
7 
14 
0 
3 d.p.f. 
i.p. 
i.p. 
i.p .• 
i.v . 
i.p .• 
i.p. 
. @ ~·P·@ 
1.p. 
i.p. 
* i.v. 
antibody 
F24-2 
SA- 12 
MB2, MB3 
MB5 I MB7 I MBll 
MB13, MB17 
86 
TB41 , TB44 
25 
28 
29,38 
29,38 
3 
34 
M. tuberculosis H37Rv 
M. tuberculosis Sl# 
Sau ton 
Sau ton 
PRES lOOS 
HKWC (108 ) 
(100 ug) 0 
15 
210 
i.p. 
i.p.* 
i.v. 
TB68, TB71, TB72 
TB73 , TB77, TB78 
aMedium used for growing mycobacteria (Culture period indicated in parenthesis): 
M. leprae and ~· lepraemurium were grown in vivo. 
bAbbreviations for antigen preparations are: swc, sonicated whole cells; SHKWC, sonicated 
heat killed whole cells; SON lS, sonicate supernatant after centrifugation at 1000 x g 
(or 20,000, 72,000, 100,000 x g): PRES lOOS, pressate supernatant obtained after 
centrifugation at 100,000 x g: we, whole cells : BPE, bacterial press extract: CCF- RaBffi ppt., 
precipitate corresponding to rabbit anti-BCG antibody obtained from concentrated 
culture filtrate ; CCF-HYTad, Concentrated culture filtrate HYT antigen depleted: CFS, 
culture filtrate solids; SLWC, sonicated lyophilized whole cells; lOKP and 30KS, pellet 
obtained after disrupting cells and centrifugation at 10,000 x g and supernatant after 
re- centrifugation at 30,000 x g; p, pellet: RSON 20S, Supernatant obtained after re-sonicating 
a pellet and centrifugation at 20,000 x g. 
cAbbreviations: i.p., intraperitoneal; i.v., intravenous, d.p. f . , days prior to fusion; 
wks., weeks; 1., liquid; s.q., subcutaneous; f.p., foot pad; i.d., intradermal. 
dSymbols: *=boost inoculation; @=adjuvant used; #=field isolate; $=absorbed with 
HYT 27 and HYT 28 . 
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TABLE l (Continued) 
IITITlunization Schedule 
Organism Medium a b Antigen (amount) Day Route c,d Monoclonal Reference 
antibody 
M. tuberculosis H37Rv Sau ton WC (2xl07 ) 0 i.p. F29-17 I F29-19, 25 
II 30 i.p. F29-23, F29- 29, 
WC ( lx108 ) 208 i.p. F29- 44, F29-47, 
F29-50 
M. tuberculosis H37Rv Sauton swc (2xl07) 0 i.p. F23-4, F23-24, 25 
II 30 i.p. F23-30, F23-41, 
II 122 i.p.* F23- 49 
II 140 i.v. 
M. tuberculosis Long HKWC (1 mg) 0 . @ l . p. HST 1, HGT 2 17 
synthetic SON 60S (100 ug) 14 i.p. HGT 3a, HGT 4, 
( 2-6 wks.) II 28 i.p. HGT 6 
fl 4 i.p.* 
SON 60S (50 ug) 3 d.p. f. i.p. 
M. tuberculosis H37Rv Sau ton (1.) BPE (100 ug) 0 i.p. HAT 1, HYT 4, 1 ,33 
II 14 i.p.* HYT 6 , HYT27 
fl 84 i.p. HYT 29 
M. tuberculosis H37Rv Sau ton ( 1.) CCF-RaBCG ppt. 0 i.p. HYT 28 33 
II 7 s . q . 
II 14 s.q.* 
fl 28 i.p. 
M. tuberculosis H37Rv Sauton (1 . ) CCF-HYTad$ (100 ug) 0 i.p. HAT 3 1 
II 14 i.p. 
II 28 i.p.* 
II 3 d . p. f. i.p. 
M. tuberculosis H37Ra Difeo 7H9 w::: (2xl07 c.f.u.) 0 i.p. TB23 7 
II 28 i . p.* 
II 93 i.p. 
M. tuberculosis H37Ra CFS (50 ug) + 0 . @ l . p. TB5-l, TB5-2 12 
HKW::: ( 5 mg) 
* 
TB5-20 
CFS (200 ug) 28 i.p. 
M. tuberculosis H37Ra Proskauer- CFS ( 100 ug) + 0 . @ l . p. TB- C-l,TB- C-2 11,32 
Beck ( 1.) HKW::: (200 ug) TB-C-3, TB-C-4 
CFS (? ug) 28 s . q. TB-C-5, TB-C-6 
II 42 s.q.* TB-C-7, TB-C-8 l.O 
CFS (400 ug) 70 i.p. TB- C-9, TB-C-10 
M. tuberculosis H37Ra Proskauer- CFS (100 ug) 0 . @ l.p. TB-C-11, TB-C-12 32 
Beck (1.) II 28 s . q . TB-C-13, TB-C-14 
II 42 s.q.* TB-C-15, TB-C-16 
CFS (400 ug) 70 i.p. TB-C-17 
M. tuberculosis H37Ra Antigen 5 (? mg) 0 . @ l.p. TB-C-18, TB-C-19 32 
Antigen 5 (1 mg) 14 ? 
? ? 
(rest 4-6 w~s . ) 
Antigen 5 (? mg) 4 d . p. f. ? 
M. leprae Armadillo 4 f.p . * F31-20, 25 \'~ (5xl08
) 0 F31-28 
WC (lxlO ) 190 i.v. F31-29 , F31-30 
M. leprae Armadillo WC (2xl07 ) 0 i.d . F41-l, 25 
II 14 i.d.* 
WC (lxl08 ) 202 i.v . 
TABLE 1 (continued) 
Irrmunization Schedule 
Organism Medium 
a Antigen b (amount) Day Route c,d Monoclonal Reference 
ant ibody 
M. leprae Armadillo swc ( 2xl08 ) 0 . d . @ 1 •• &1.p. F26-3, F26-4, 25 
" 10 i.d.* F26- 6 , F26-7 
soc (lxl09 ) 42 i.v. 
M. leprae Armadillo swc (2 . 5xl0
8 ) 0 . d . @ 1 •• &1 .v. F30-5, F30- ll, 25 
" 17 i.d.* F30-14 
swc (lxl09 ) 47 i.v. 
M. leprae Armadillo SLOC (lxl09 ) 0 i.p. ML30 I ML34 16 
" 30 i.p. 
" 60 i.p.* 
" 90 i.p. 
M. leprae Armadillo SON lOOS ( 100 ug) 0 
. @ 
ML02, ML09 16 7·P•@ 
" (? ug) ? 1.p. 
" (? ug) 168 ~·P• @ 
? 3 d . p. f. 1.p. 
M. leprae Armadillo lOKP ( 50 ug) + 0 i.p. IVD2 1 IVE12 14 
30KS (100 ug) 
" 6 i.p. 
" 12' i.p.* 
II 22 i.p. 
M. leprae Armadillo SON 20S (SO U9) + 0 
. @ 
1.p. Ll I L2 I L3 I L4 33 
P (SO ug) 
• @ II 7 1.p. 
II 14 i.p.* 
II 30 i.v. 
M. leprae Armadillo SON 20S (SO ug) 0 
• @ 
L7 I L8, L9, 33 7•P•@ 
II 7 1.p. LlO 
II 14 i.p.* 
II 180 i.v. 
M. leprae Armadillo RSON 20S i!TITlunize and L14, L21, L22 4 
rest for 180 L2S 
days 
* RSON 20S 3 d.p.f. 
M. leprae Armadillo SON 27S (SO ug) 0 
• @ 
SAl. D2D 43 ....... 1.p. ....... 
II 7 i.p. 
II 14 i.p. 
II 21 i.p.* 
II 3 d.p.f. i.v. 
lepraemurium Mice or WC (lxl08 ) 0 i.v.* A-494 2 
Rats ll ll i.v. 
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for 1 hour, 1133 and an immunoprecipitate from concentrated culture 
filtrate (CCF). 1133 The immunoprecipitate was obtained by crossed 
immunoelectrophoresis (CIE) with CCF electrophoresed in second 
dimension into an agarose gel containing rabbit anti M. bovis BCG 
(RaBCG) serum followed by excision from the gel. The CCF was prepared 
from M. tuberculosis H37Rv grown in Sauton fluid medium42 • The cells 
were removed by filtration and antigen was precipitated using ammonium 
sulphate, resuspended in PBS, and centrifuged at 44,000 x g to remove 
insoluble material . 33 Three McAb HYT 6 , HYT 27 and HYT 28, resulting 
from immunization with BPE and hybridoma production, were then used to 
construct an immunosorbent matrix by coupling to CNBr-activated 
Sepharose 4B. 1133 The CCF was depleted of antigens corresponding to 
HYT 6 , HYT 27, and HYT 28 after passage through the affinity column . 
The CCF effluent (CCF-HYTad) was then used for immunization and 
hybridoma production. 1 Mycobacterium tuberculosis strain Sl HKWC was 
used as a boost inoculum in one immunization schedule . 7 Antigens from 
M. tuberculosis H37Ra were used in the form of wc., 7 dried HKWc, 11 112 132 
and culture filtrate solids11112132 (CFS) prepared after pellicle 
growth in Proskauer-Beck synthetic medium26 for eight to ten weeks 
followed by filtration, dialysis of the filtrate against water, and 
lyophilization.10 Antigen 5 from M. tuberculosis H37Ra unheated 
culture filtrate, obtained after absorption onto an immunosorbent 
1 d . t t . 8 ,g al d f . . . co umn prepare using goa an 1serum, was so use or immun1zat1on 
in hybridoma production. 32 The goat antiserum was prepared using 
13 
Ant igen 5 that was obtained after acrylamide gel separation of material 
recovered by concanavalin A- Sepharose chromatography. 
Although McAb were pr oduced to investigate antigens of M. leprae 
or M. lepraemurium, some of these McAb detect antigens of M. bovis BCG . 
Mycobacterium leprae used for antigen preparation was i solated from 
livers of infected armadillos. Antigens obtained from M. leprae 
included ~~ , 25 dry weight swc, 25 sonicat ed lyophilized whole cells 
(SLWC) ,16 sonicate supernatant (SON l OOS) obtained after 60co 
irradiation of cells followed by ultrasonication and centrifugation at 
100 ,000 x g for 1 hour, 16 or centrifugation of fractions lOKP and 
30Ks. 14 The l OKP fraction was prepared by extracting acetone treated 
cells in a lithium acetate-ethylenediaminetetraaceti c acid (EDTA) 
solution for 2 hours at 45°c and cell wall material and damaged cells 
were removed by centrifugation at 10 ,000 x g for 10 minutes. The 
remaining supernatant was centrifuged for 20 minutes at 30 ,000 x g and 
the final supernatant was dialyzed against H2o, lyophilized, and 
resuspended in phosphate buffered saline (PBS) t o obtain 30KS . Other 
centrifuge fractions were prepar ed by ultrasonicating lyophilized whole 
cells and centrifuging at 20 ,000 x g for 15 minutes to obt ain soluble 
sonicate (SON 20S) . 3 The remaining pellet was _resonicated and after 
centrifugation at 20,000 x g , the final pellet (P) 3 and supernatant 
(RSON 20S) 3 were also used for immunization. Mycobacterium leprae was 
also sonicated and centrifuged at 27,000 x g for 30 minutes to obtain 
supernatant antigen (SON 278) . 43 Mycobacterium lepraemurium we, grown 
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in vivo in a susceptible mouse or rat strains, were also used as 
antigen for irrmunization and McAb production. 2 
Mycobacterial antigen preparations included heat killed or non-
heat killed organisms, and ranged from intact whole cells to disrupted 
cells and resulting fractions. Immunization schedules using 
mycobacterial antigens consisted of repeated inoculations and a final 
boost injection three to four days prior t o fusion and hybridoma 
production (Table 1). Time for immunization, including boost , varied 
from 11 days to 362 days however a 30 to 90 day interval was rrost 
common . Freunds incomplete adjuvant was frequently used with the 
initial inoculation. Routes of inoculation for various immunizations 
were intraperitoneal, intravenous, subcutaneous , intradermal, or in one 
schedule via the foot paa. 25 
· Techniques used to produce McAb to mycobacteria involve fusion of 
spleen cells obtained from immunized mice with inunortal myeloma 
cell s. 20127 Myeloma cell lines used in hybridoma production have 
included p3- NSI /l-AG4_1 ,3,4,7,ll,12,14,16 ,29, 32 ,34,38,43 Sp2/0 ,l7125 
and P3X63-Ag8.653 . 2128 Myeloma cell line P3-NSI/l-Ag4-l is a variant 
clone from myeloma P3K that produces MOPC 21 protein and is resistant 
to 20 ug/ ml 8-azaguanine. 23 P3-NSI/l- Ag4-l does not produce 
immunoglobulin (Ig) heavy chain and produces kappa light chain but it 
is not secreted . Myeloma P3X63-Ag8 , derived from P3K, is resistant to 
20 ug/ml 8-azaguanine and secretes MOPC 21 IgGl (kappa) , 21 and was used 
to generate Sp2/0 after fusion with spleen cells from mice immunized 
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with sheep red blood cells. 35 Sp2/ 0 does not express Ig heavy or light 
chains. 22 Myel oma P3X63- Ag8 was repeatedly cloned and subclone P3X63-
Ag8 . 653 was isolated which does not express Ig heavy or light chain . 18 
An additional myeloma cell line, FOX-NY was a spontaneous mutant from 
P3- NSI/ l-Ag4-l . 37 Stimulated spleen &-cells that produce antibody were 
fused with myeloma cell using inactivated Sendai virus21 or by 
polyethylene glycol . 13 Fusion of plasma membranes results in formation 
of a cell containing two or more nuclei. At cel l division, the nuclei 
fuse and a hybrid cell results. Hybridomas are differ entiated from 
myeloma cells and unfused cells after gr owth in selective medium. In 
order to multiply in culture, a cell must replicate its DNA. There ar e 
two pathways in which purines and pyrimidines are synthesized for 
incorporation into DNA . 36 In the de~ pathway, ribose 5-phosphate , 
glycine , aspartate, glut amine , CD2, and carbon atoms from 
tetrahydrofolate are utilized to produce inosinate ( IMP ) which is a 
pr ecur sor in synthesis of deoxyadenylate (dATP ) and deoxyguanylate 
(dGTP) that are incorporated i nto DNA. Tetrahydrofolate also is a 
methyl donor in the synthesis reaction converting deoxyuridylate (dUMP ) 
to deoxythymidylate (dTMP) that is needed in DNA synthesis. · In the 
salvage pathway, adenine phosphoribosyl transferase (APRT ) catalyzes 
transfer of the ribose phosphate moiety of 5-phosphoribosyl-1-
pyrophosphate (PRPP) to adenine forming adenylate (AMP) and thymidine 
kinase ( TI<) catalyzes formation of dTMP from thymidine and r i bose 
phosphate. 31 Cells can synthesize DNA via the salvage pathway if 
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adenine and thymidine are supplied in the medium. Aminopterin blocks 
conversion of dihydrofolate to tetrahydrofolate in t he de ~ pathway 
and cells gr owing in the presence aminopterin synthes ize DNA by salvage 
pathways. FOX- NY myeloma cells are deficient in APRT and can not 
survive in aminopterin supplemented medium. In B-cells from 
Robertson ian (8 . 12) 5 Bnr [Rb(S .12)] mice the heavy chain Ig locus on 
chromosome 12 and the APRT locus on chromosome 8 are genetically 
linked. 37 After fusing B-cells with FOX- NY myelomas, cells are gr own 
in medium supplemented with aminopterin , adenine , and thymidine (AAT); 
only hybridomas that produce antibody have APRT and can survive . 
Supernatants from cell cultures are screened to detect antibody with 
activity t o the target antigen. Cell cultures with supernatants 
positive for antibody activity are expanded and corresponding McAb are 
characterized . 
Monocl onal antibodies obtained from actively secreting hybridomas 
were partially characterized by determining immunoglobulin (Ig) 
isotype, evaluating binding activity to other mycobacterial and non-
mycobacterial antigens, and by estimat ing the molecular mass of 
corresponding antigenic components . Immunoglobulin subclass 
determination of McAb was performed using 
imrnunodiffusion213112114 116125 129 132 or isotyping antisera 
techniques17 128 (Table 2) . The majority of McAb produced have been Ig 
class M (IgM) . Other Ig subclasses included IgG1 , IgG2a' IgG2b ' and 
IgG3• Two McAb produced with binding activity t o M. bovis antigens 
17 
were Ig class A (IgA) . 29 132 Generally, immunization periods of 30 days 
or less resulted in production of hybridomas secreting IgM McAb . 
Binding activit ies of McAb to mycobacterial and non-mycobact erial 
antigens were evaluated by radioimmunoassay (RIA), ELISA , and 
immunofluorescence. Bacterial antigen SON l S was used t o evaluate MB2 , 
MB3 , MB5, MB7 , MBll , MB13 , and MB17 binding in RIA. 29138 
TABLE 2 . Immunoglobulin subclass of rronoclonal antibodies 
Subclass 
IgM IgM IgGl IgG2a IgG2b IgG3 IgA 
F24-2 TB-C-1 TB23 SA- 12 TB71 B6 MB17 
MB2 TB-C- 2 TB68 MB5 TB5-20 F23- 4 TB-C- 18 
MB3 TB-C- 3 TB72 F23-4l ML02 
MB7 TB-C-4 TB78 F23-49 ML09 
MBll TB-C- 5 F23- 24 F29-29 L9 
MB13 TB-C-6 F26- 6 TB-C-13 LlO 
TB73 TB-C-7 F29- 23 TB-C-14 
TB77 TB-C-8 F29-50 TB-C-15 
F23- 30 TB-C- 9 TB5- 2 L4 
F26-3 TB-C-11 HGT l L25 
F26-4 TB-C-11 HGT 2 
F26-7 TB-C-12 HGT 4 
F29-17 TB-C-16 HGT 6 
F29-19 TB-C-17 HYT 6 
F29- 44 TB-C-19 HYT 27 
F29-47 HGT 3a HYT 28 
F30- 5 HAT l HAT 3 
F30-ll IVD2 ML30 
F30-14 IVE12 L7 
F31- 20 ML34 Ll4 
F31-28 Ll L21 
F31-29 L2 L22 
F31-30 L3 SAl . D2D 
F41-l LS 
TB5- l A- 494 
18 
Antigens detected using MBS were restricted to M. bovis vallee, AN-5, 
and 44 field isolates of M. bovis. The remaining MB McAb were used t o 
demonstrate binding activity to a wide range of mycobacteria, and i n 
the case of MB3 and MB17, to detect E. coli intracellular antigens . 
Inhibition evaluations using SON lS confirmed binding activity patterns 
of MB McAb to mycobacterial antigens. MBS binding activity was 
inhibited by M. bovis field strain 2309 and strain vallee antigens but 
not by M. bovis BCG. In contrast, MB3 , and MB17 binding was i nhibited 
by each mycobacterial sonicate tested. Binding of SA- 12 t o 
corresponding radiolabeled BCG-a antigen was inhibited by !:!· bovis BCG 
(Glaxo ) , ~· tuberculosis SON 200S, and weekly by M. fortuitum, !:!· 
intracellulare, and M. kansasii SON 200s. 28 Mycobacterium bovis BCG 
HKWC also inhibited SA-12 binding to corresponding antigen scx;- a. 
Sonicates from non-mycobacterial species did not inhibit SA-12 bindi ng 
activity. As determined by RIA using PRES l OOS from bacteria tested7 , 
TB68 was used t o detect antigens of !:!· bovis and !:!· tuberculosis. 
Monoclonal antibodies TB23 , TB73 , TB77 , and TB78 were used to detect M. 
tuberculosis complex antigens and antigens from other mycobacterial 
species, where use of TB73 and TB77 also detected ~- coli ant igen. Of 
the McAb recognizing antigens of M. bovis, use of TB23, TB77 , and TB78 
detected antigen of M. bovis vallee and did not detect antigens of BCG, 
TB68 and TB73 de tected antigen in both strains . Only antigens of !:!· 
tuberculosis were detected using TB71 and TB72 . The ability of PRES 
l OOS from mycobacterial species to inhibit 125I labeled McAb binding to 
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homologous antigen was also determined to evaluate binding activity. 
TB68 and TB23 were inhibited by M. bovis vallee and M. tuberculosi s 
H37Rv antigens, but not by .!'.!· bovis BCG antigens . High concentrations 
of M. bovis vallee antigen inhibited TB71 and TB72 bindi ng to M. 
tuberculosis H37Rv antigen . As for McAb produced with the intent to 
detect M. leprae antigens, use of ML02, ML09, ML30 , and ML34 detected 
M. bovis SON lOOS and other mycobacterial antigens in RIA.16 Binding 
patterns and inhibition of radiolabeled ML McAb by other ML McAb 
indicated that the same determinant was detected using MLOl and ML02 . 
Binding of ML34 was inhibited by ML01/ ML02 suggesting that it 
recognized a similar determinant . ML34 was not inhibited by any other 
ML McAb. 
Binding activities of McAb were evaluated by ElISA and IF. As 
determined by ELISA, use of TB44 detected glycolipid C from M. bovis 
BCG and not glycolipid A and B antigens, 34 and B6 was broadly reactive 
to SON 20S antigen form a range of mycobacteria. 3 The F23 McAb and 
F24- 2 were used to detect M. bovis BC'G and M. tuberculosis antigens as 
determined by ELISA using SON 20S and by IF with HKWC antigen . 25 Use 
of all F23 McAb , except F23-44, detected antigens from rrore 
mycobacteria than F24-2. In addition , F24-2 was used to detected 
antigen form chloroform- water extract of M. bovis BCG in ELISA. 
Detection of M. bovis BCG antigen by use of F29- 23 and F29- 50 was 
evident only in IF using HKWC antigen , and antigens from other 
mycobacteria were also detected. The McAb F29-17 , F29-19, F29-29 , F29-
20 
44, and F29-47 indicated stronger binding activity to M. bovis, M. 
tuberculosis, and other mycobacteria in ELISA using HKWC instead of 
sonicates, and this observation was supported in IF using HKWC antigen. 
overall, F26, F30, and F31 McAb had low specificity. Fusion 41 
hybridomas were screened using HKWC in IF and use of F41-l detected M. 
bovis and other mycobacterial antigen in IF and not in ELISA. Antigen 
5 and Antigen 6 was detected in ELISA using TB-5- 1, TB-5-2, and all TB-
c.11 112132 McAb TB- C-1, TB- C- 2 , TB- C-5 , TB-C- 6 , TB-C-7, TB-C-8, TB- C-
11, TB-C-12 , TB-C-16, and TB-C-17 were reactive to CFS from a broad 
range of mycobacteria, and TB-C-3 , TB-C- 4, TB-C- 9 , TB- C-10 , and use of 
TB-C-19 also detected CFS antigen from some mycobacteria, but reacted 
stronger to antigen 5 and 6 . Only use of TB-C-13 , TB-C-14, TB-C-15 and 
TB-C-18 detected Antigen 5 and 6 specifically. Formaldehyde-killed 
whole cells were used t o evaluate HYT McAb by ELISA . 1133 Monoclonal 
antibody HYT 28 was used and only detected antigens of M. tuberculosis 
of all the mycobacteria tested, whereas use of HYT 4, HYT 27 , and HYT 
29 identified antigen of M. bovis BCG and antigen of other 
mycobacteria . Similarly. HYT 6 , HAT 1, and HAT 3 were used t o detect 
CCF and BPE antigens from a range of mycobacteria. Binding activity of 
HGT McAb were evaluated by ELISA using mycobacterial SWC antigen and 
HGT 4 exhibited strong binding to M. bovis BCG and M. tuberculosis and 
moderate binding activity t o !:!· kansasii and M. scrofulaceum. Use of 
HGT 1, HGT 2 , and HGT 6 did not detec t antigens of M. bovis, although 
SWC antigen of M. tuberculosis and other mycobacteria were detec ted. 
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HGT 3a binding activity was limited t o M. tuberculosis of the 
mycobacteria tested. 
McAb obtained after immunization with M. leprae antigens that 
detected M. bovis antigens, with exception of L7, were of low 
specificity and could be used t o detect antigen from numerous 
b . 3 myco acter1a. Binding activity of L7 was greater with M. bovis SON 
20S antigens than to M. tuberculosis, !!· leprae, and !!· scrofulaceum 
SON 20S antigens. 3 Sonicates from eleven spec ies of mycobacteria were 
used t o determine binding of L21 and L22 in ELISA . 4 Ant igens from 
each of M. bovis sex;, M. tuberculosis H37Rv , M. gastri, M. 
intracellulare, !!· leprae, M. nonchromogenicum, !!· phlei, !!· simiae, M. 
smegmatis, M. ulcerans, and M. vaccae were detected by use of L21 and 
L22. L21 and L22 were also used to detect whole bacilli in IF. In 
ELISA using 30KS antigens, IVD2 had greater binding activity as 
compared t o IVE12 . 14 As detected by IF using WC antigens, A- 494 was 
also br oadl y reactive to mycobacterial species , as well as to antigens 
of Nocardia. 2 
Molecul ar weight (MW) of antigenic components corresponding t o 
McAb were estimated using i mmunoblot procedures39 (Table 3) . The MB 
McAb that was used t o detect antigens of !!· bovis were analyzed by 
immunoblot techniques under reducing conditions using SON lS antigen 
from M. bovis sex; , M. tuberculosis, M. africanum, M. avium, and M. 
paratuberculosis . 28 Antigenic components detected by use of MBS were 
from a field isolate of M. bovis and included one major component of 
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Tabl e 3 . b 
. a , b 
Characterization of monoclonal antibodies t o myco acter1a 
, lonoclonal 
Antibody 
::olecular '.·leight 
(kilo )c 
\Ja t~re ~f 
Antigen 
Immunoblot 
Speci ficity Reference 
F23- 24 
F26- 3 
F26- 6 
F29- 17 
F29- l9 
F29- 23 
r29- 44 
F29- 50 
F31- 20 
i.JB3 + 
HAT l 
HAT 3 
L7 
TB78 
Ll4 
L25 
ML3~ 
L21% 
L22 
HGT l 
HGT 2 
HGT 4 
HYT 29 
ML34 
1'1L02 
>200 
>200 
>200 
>200 
>200 
>200 
>200 
>200 
>200 
200- 20 
71 
71 (m. b . ) 
70 
65 (m . b . ) 
65 
65 
65 , 55 ,50- 28(s) 
65 , 12 
65 ,12 
60-45 (m . b . ) 
60- 45 (m . b . ) 
60- 28 (m . b . ) 
57 , 33 , 32 
50- 40 (s) 
50- 40 ( s ) 
non-protein 
non-pr o t ein 
non-protein 
non-pr o t ein 
non-pr otein 
non- pr ot ein 
car bohydr a te 
protein 
protein 
pr ot e in 
pr ot ein 
protein 
pr ot ein 
protein 
pr otein 
pr ot ein 
pr otein 
car bohydrate/ lipid 
carbohydrate/lipid 
CR 
CR 
CR- 8 
CR- L 
CR- L 
CR 
CR 
CR 
CR 
CR 
CR- 8 
CR- 8 
CR- L 
CR 
CR 
25 
25 
25 
25 
25 
25 
25 
25 
25 
29 
1 
1 
3 
41 
4 
4 
40 
4 
4 
17 
17 
17 
33 
16 , 40 
16 , 40 
aAbbr eviations : s , smear ; m. b . , multiple bands ; CR , cross reactive 
( - L, limited ; - B, br oad) ; Mtb- C, ~- tuberculosis complex . 
bSyrnbols : +=cr oss r eactive with tissue antigens; A=cross r eactive 
with bovine serum albumin ; -=additional component de tected in 1 . 
africanum and M. avium ; % 1 ~ 1*1 ~ 1 $ 1 &=~onoclonal an tibodies (McAb) 
t o the same antigen . 
c 1olecular we i ght was de termined by immunobl ot pr ocedures . 
dAs indicated by susceptibility t o pr oteolytic digest ion . 
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Table 3 (Continued ) 
Monoclonal Molecular Weight Nature 8f Immunoblot 
Antibody (kilo)c Antigen Specificity Reference 
ML09 50-40 (s) carbohydrate 16 
HGT 6 45,43 CR- B 17 
F2f- 29 40 protein CR-1 41 
11# 40-30 (s) carbohydrate CR 3 
19 40-30 (s) carbohydrate CR 3 
110# 40-30 (s) carbohydrate CR 3 
* TB72 
* 
38 protein Mtb- C 41 
HYT 28 38 protein Mtb-C 41 
HGT 3a 38 Mtb-C 17 
TB71 38 protein Mtb-C 41 
HYT 27 33,32 protein CR 1 
MB5 29.8,22 .9,19.9 M. bovis 29 
TB-C-1 26.8 (m.b.) carbohydrate CR 11 
SAl.&20 23 protein CR- B 41 
TB23 19 protein CR-1 41 
F29-4@@ 19 protein CR-1 41 
HYT 6 19 protein CR-1 1,41 
TB-C-13 19 protein ? (weak activity) 41 
HYT 4 19-17 protein 33 
MB17 17.4 (16-) CR 29 
F23-~l <15 25 
TB68 14 protein Mtb-C 41 
F24-2$ 14 protein Mtb-C 41 
F23-49$ 14 protein Mtb-C 41 
SA-12 12 protein CR-L 41 
B6& 6-4.5 (s) carbohydrate CR 3 
13& 6-4.5 ( s) carbohydrate/lipid CR 3,40 
L4& 6-4.5 (s) carbohydrate CR 3 
24 
29 .8 kilo (k) and two minor components of 22.9 k and 19 . 9 k. Multiple 
bands in the range of 100 to 20 K were detected by use of MB3 from the 
field isolate of M. bovis and each of the mycobacterial cell sonicates 
examined. Broadly reactive MB17 was used to detect a major 17 . 4 k 
component in each mycobacterial cell sonicate, and a minor 16 k 
component in M. africanum and M. avium. 
The F24, F23, F26, F29 and F31 McAb were analyzed in immunoblot 
using the same sonicates from the homologous organism as used in 
immunization and hybridoma production. 25 Antigens were 
electrophoresed in the presence of SOS under reducing conditions . Use 
of F23- 24, F26- 3 , F26-6, F29-17, F29-19 , F29-23 , F29-44, F29-50 and 
F31-20 detected a component with MW greater than 200 k . Use of F24- 2 , 
F23-41 and F23-49 detected antigens from M. bovis BCG sonicate with MW 
in the range 15 k to 14 k. Components detected by use of F29-29 and 
F29-47 were 4 k and 19 k respectively . In general, F29 McAb reacting 
with antigens of high MW were heat and SOS stable and insensitive to 
pronase treatment . Antigens detected by use of F29- 29, F29-47, F23-49 , 
and F24- 2 were sensitive to proteolytic digestion indicating protein 
composition . 
The McAb TB-C-1 was used in immunoblot analysis with CFS form ~· 
tuberculosis, M. gordonae, M. intracellulare, M. kansasii, and M. 
scrofulaceum. 11 Four components were detected in M. tuberculosis and 
M. intracellulare with MW of 58 k, 28.5 k, 26 .8 k , and 25.5 k. The 58 
k component was also detected in M. scrofulaceum and the 28 . 5 k 
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component was detected in ~· kansasii. The 26 .8 k component was 
detected in CFS from each of the five mycobacterial species tested. 
Antigens recovered by TB-C-1 affinity chromatography consisted of 
arabinomannan and arabinogalactan. The 19 k component was weakly 
detected by use of TB-C-13 and was considered protein in composition . 41 
To estimate the MW of antigenic components corresponding to HYT 
McAb, CCF, BPE , and a saline extract from M. tuberculosis were 
1 t h ed d d . d. . 1,33 ,41 e ec rop ores un er re ucing con 1t1ons. Immunoblot analysis 
using CCF and BPE indicated similar results where use of HYT 29 
detected 57 k, 33 k and 32 k components, HYT 28 identified a 38 k 
component, HYT 27 was used to detected 33 k and 32 k components, and 
use of HYT 4 detected 19 k and 17 k components. When a saline extract 
of M. tuberculosis was used in immunobl ot analysis, use of HYT 4 and 
HYT 27 detected similar components as were detected in CCF and OPE 
preparations, a 32 k component was detected using HYT 29, and use of 
HYT 28 failed to detect antigens. The HYT McAb were also evaluated 
using CIE techniques and could be grouped on the basis of binding 
activity as they were after immunoblot analysis. 33 The CIE precipitate 
reactive with HYT 28 was indistinguishable from the CIE precipitate 
used to immunize mice for hybridoma production. The antigens CCF, BPE , 
or crude cell wall extract (CCWE) from M. bovis sex;, M. kansasii, M. 
aviurn, M. fortuitum, M. intracellulare and M. marinum were also used to 
evaluate binding activity of HYT and HAT McAb. HYT 28 was used to 
detect a 38 k component in each antigen preparation from M. bovis BCG, 
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whereas use of HYT 27 detected antigens of M. bovis in only CCF and 
CCWE. In addition, !!· avium antigens in CCF and CCWE, M. fortuitum 
antigens in CCF and BPE, M. intracellulare antigens in BPE and CCWE, 
and components in CCF, BPE, and CCWE from M. kansasii and M. marinum 
were detected using HYT 27. A 71 k component was detected by use of 
HAT 1 in CCF and BPE from each mycobacteria tested except !!· fortuitum, 
in CCWE from each mycobacteria tested except M. kansasii and M. 
marinum, and from sonicated Nocardia asteroides. HYT 6 was used to 
detect a 19 k component in each antigen preparation from each 
mycobacterial species tested except !!· fortuitum. Multiple components 
were detected by use of HAT 3 in each antigen preparation from each 
mycobacterial species tested as well as from sonicated N. asteroides 
and Rhodococcus erythropolis. Using CCF, HYT27, HYT28, and HATl 
detected determinants of M. tuberculosis H37Rv that were heat sensitive 
as determined by ELISA and irrununoblot results. 1 All determinants 
detected using HYT and HAT McAb were pronase sensitive . 1 Lectin 
chromatography using a sepharose-concanavalin A matrix was perforrred to 
isolate antigens from M. tuberculosis H37Rv CCF which were detected by 
use of HYT6 and HATl implying associated carbohydrate . 1 
Sonicated !!· tuberculosis was used as antigen under reducing 
conditions in irmnunoblot to determine MW of components detected by use 
of HGT McAb. 17 Multiple bands detected by use of HGT 1/ HGT 2 wece in 
range 60 to 45 k, HGT 3a was used to detect a single 38 k component, 
60- 28 k components were detected using HGT 4, and HGT 6 was used to 
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identify 45 k and 43 k components. Immunoblots were performed using 
antigens f rom M. bovis Bex;, M. kansasii , M. avium, M. intr acel l ular e , 
M. phlei, M. scrofulaceum, M. smegmatis, M. vaccae, E. coli, and N. 
ast eroides . A 38 k component was detected in M. bovis and M. 
tuberculosis by use of HGT 3a. Use of HGT 4 detected multiple 
components in M. bovis, M. tuberculosis, M. kansasii, and N. 
asteroides. Use of low specificity HGT 6 detected antigens in N. 
asteroides and each mycobacterial species tested except M. vaccae and 
M. phlei . Similarly, use of HGT !/HGT 2 detected components in~- coli 
and N. asteroides and each mycobacterial species tested except M. 
vaccae. 
Antigens used in immunobl ot analysis of B6 included sonicate 
super natant (SON 20S), the corresponding pellet (P), and supernatant 
from resonicated pellet (RSON 20S). 3 The McAb B6 was used to detect a 
6 kD component in SON 20S and P and was considered to be carbohydrate. 
Of the McAb directed against ~- leprae, those with binding 
activity to M. bovis were also analyzed by immunoblot techniques. 
Sonicate supernatant antigen was used under reducing conditions to 
estimate MW of components corresponding to ML McAb. 16140 Antigenic 
components detected by use of ML30 were 65 k, 55 k, and 50 to 28 k and 
the antigen was sensitive to subtilisin treatment. Antigens detected 
using ML02/ML09 or ML34 were 50-40 k and were resistant to digestion by 
subtilisin, implying polysaccharide or glycolipid. Antigens from 
mycobacteria other than M. leprae were detected by use of MI..02, ML09, 
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M130, and M134 . 
Antigens used in inununoblot analysis of 11-10 , 114, and L25 
included sonicate supernatant (SON 20S), the corresponding pellet (P) , 
and supernatant from resonicated pellet (RSON 20S) of M. leprae. 3 ' 4 
Use of L3 and 14 detected a 6 k component in SON 20S and P, Ll, L9, and 
LlO were used to detect components 40 to 30 k, and 17 identified a 70 k 
component. Antigens of M. bovis and M. tuberculosis were also detected 
by use of L4, 17, and L9. Antigenic components approximately 40- 30 k 
and 6 k were resistant t o subtilisin proteolysis and 70 k and 16 k 
components were sensitive to proteolysis. Use of cross-reactive Ll4 
and L21 detected a 65 k antigen, and use of L22 and L25 detect 65 k and 
12 k components. The 65 k antigen was also sensitive t o proteolysis 
and was considered protein in nature. 
The World Health Or ganization (WHO) established workshops des igned 
t o characterize McAb produced against mycobacteria.41 The MW of 
antigens were determined using immunoblot pr ocedures and Mc Ab were 
classified as protein in nature on the basis of sensitivity to 
proteolytic digestion by subtilisin. The McAb SA-12, produced against 
M. bovis, was used to detect a protein antigen with MW of 12 k and 
exhibited cross-reactive activity. Use of TB78, TB72 , TB71, TB23, and 
TB68 detected 65 k (multiple bands), 38 k, 38 k, 19 k, and 14 k 
components and each antigen was considered to be protein . The 
specificity of TB72, TB71, and TB68 were directed toward the M. 
tuberculosis complex and limited cross-reactivity was demonstrated by 
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use of TB78 and TB23. Monoclonal antibody SAl.020 was used to detect a 
23 k component composed of protein and exhibited broad cross-
reactivity. Additional information from inhibition studies was 
provided by WHO. The same antigen (38 K) was detected by use of TB72, 
HYT 28, and TB71, although TB71 and TB72 did not identify the same 
determinant. The same antigen (19 K) was detected by use of TB23, F29-
47, and HYT 6 and TB68, F24-2, and F23-49 were used to detect the same 
antigen (14 K). I n addition, Ll, L9, and LlO were considered to 
identify simular determinants on the same antigen3 and use of L21 and 
L22 detected the same antigen. 4 
Considering the common use of purified protein derivative (PPD) as 
a skin test antigen, it is of interest to evaluate McAb binding 
activity to PPD . The MB McAb were used to analyze PPD antigens in RIA 
and MB3 detected antigens of ~· bovis, ~· avium, and M. 
paratuberculosis. 29 In contrast, use of MBS and MB17 did not detect 
antigens in the PPD tested. 15 The McAb TB72, TB71, TB68 , TB78 , TB23 , 
ML30, and ML34 were also evaluated in RIA using PPD. Only use of TB68 
and ML30 detected antigen of M. bovis PPD. Culture filtrate from M. 
tuberculosis was used to prepare PPD and, when evaluated in ELISA, TB-
C-1 detected antigens where as TB-C-13 did not detect antigen. 11 As 
determined by ELISA and immunoblot, use of HYT6 and HAT3 detected 
components in tuberculin PP0. 1 Antigens corresponding to HYT 27 , HYT 
28, and HAT l were sensitive to heat treatment (similar to that used in 
preparation of PPO) and were not detected by immuoblot procedures. 
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SECTION I. OPTIMIZATION OF HYBRIDOMA PRODUCTION AND PARAMETERS FOR 
DETECTION OF ANTIBODY 'IO Mycobacterium bovis 
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SUMMARY 
Somatic cell hybridization parameters including inoculum 
concentration for immunizing mice, cell suspensions in fusions, and 
media composition were optimized for production of hybridomas secreting 
monoclonal antibody. Heat- killed whole cell inoculum at 5 mg/ml wet 
weight was adequate for immunizing Robertsonian mice to generate primed 
B-lymphocytes. Hybridoma colonies were obtained in approximately 90% 
of the wells when a myeloma-B-lymphocyte fusion mixture was resuspended 
in culture medium containing FOX-NY myelomas and plated. Addition of 
arnphotericin B (3 mg/ml to cell culture medium) did not influence the 
viability of hybridomas. Enzyme linked irnrnunosorbent assay parameters 
were adjusted to detect anti-Mycobacterium bovis binding activity to 
increase accuracy for selecting stable hybridomas. Heat killed M. 
bovis cells were bound to microtiter plates by wet binding overnight at 
4°c. Supernatant containing monoclonal antibody was used as primary 
antibody. Goat anti-mouse antibody (H+L) conjugated to horseradish 
peroxidase was used at serial dilution 1 to 500. Optical density 
values recorded after 30 minutes of enzyme-substrate reaction were used 
to determine a positive test reaction. Two hybridoma cell lines 
selected as positive controls had optical density values 5 fold greater 
than negative control values. Optical density values of test 
supernatants from other viable hybridomas with stable antibody 
production were similar. Supernatants were used at dilution 1 to 9 in 
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enzyme linked irrununosorbent assay for initial screening of hybridomas . 
Optimization of enzyme-linked irrununosorbent assay parameters allowed 
efficient use of rronoclonal antibodies for detection of Mycobacterium 
bovis antigens. 
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INTRODUCTION 
Development of somatic cell hybridization techniques and 
production of monoclonal antibodies31417 (McAb) provides t he tools 
necessary for analyzing bacterial antigens on a molecular level. The 
complex antigen structure of .mycobacteria can be explored by using McAb 
directed against various antigenic determinants of this organism. The 
majority of McAb detecting mycobacterial antigens have been pr oduced to 
M. tuberculosis and M. leprae, 15 and few McAb exist that detect 
antigens from virulent M. bovis . Myeloma cell lines used in hybridoma 
production have been based on a hypoxanthine phosphoribosyl transferase 
selection system where the l ocus for this selectable marker is located 
on the X chromosome. 1 An alternative selection strategy utilizes the 
FOX- NY myeloma cell line and Robertsonian (8.12) 5 Bnr [Rb (8.12)] 
mice. 12 In Rb(8.12) mice, the heavy chain immunoglobulin locus on 
chromosome 12 is genetically linked to the adenosine phosphoribosyl 
transferase (APRT) selectable marker locus of chromosome 8. Hybridoma 
selection based on APRT activity requires presence of both heavy chain 
and selectable marker loci. Thus, an added advantage of this system is 
that hybridomas not producing immunoglobulin , encoded by the fused 8-
cell, are e l iminated as a result of simultaneous l oss of APRT activity. 
In order to maximize the number of hybridomas obtained after a 
fusion experiment, comparisons of inoculum concentrations used to 
immunize mice , fusion mixtures, and of media compositions were made. 
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Success of a fusion experiment was indicated by the number of hybridoma 
colonies per fusion plate and percentage of colony supernatants 
containing antibody with activity to M. bovis ATCC 19210 heat-killed 
whole cell (HKWC) antigen. Antibody activity in supernatants from 
hybridomas was evaluated by using an enzyrre linked irranunosorbent assay 
(ELISA). Parameters were adjusted in the ELISA to allow selection of 
stable hybridomas producing antibody, which included, reading time 
after initiation of enzyme-substrate reaction, establishing a positive 
control, and dilution of hybridoma supernatant used for screening 
fusions. 
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MATERIAL AND METHODS 
Bacteria 
Mycobacterium bovis ATCC 19210 (neotype) was obtained from the 
American Type Culture Collection. Organisms were grown on Middlebrook 
and Cohn 7Hl0 agar base medium (Difeo Laboratories Inc., Detroit, MI) 
to which Middlebrook OADC enrichment (Difeo Laboratories Inc., Detroit, 
MI) and pyruvate (4.1 g/ L) was added,6 or Middlebrook and Cohn 7Hl0 
agar base medium (BBL Microbiology Systems, Cockeysville, MD) to which 
pyruvate (8 .2 g/ L), L-asparagine (5.0 g/ L) , L-glutamic acid (6 . 0 g/ L), 
and dextrose (30 g/L) was added. Cultures were incubated at 37° C. 
Cells were harvested at 6-8 weeks and used for antigen preparation. 
Antigen Preparation 
Harvested cells were washed twice by resuspension in sterile 
deionized and distilled H2o followed by centrifugation at 10 ,000 rpm. 
The resulting pellet was weighed, resuspended in sterile phosphate 
buffered saline (PBS) to cell suspensions of 10 mg/ ml and 50 mg/ ml (wet 
weight), and autoclaved for 10 minutes at 121° c. The HKWC antigen was 
used for immunizing mice, for ELISA evaluations, and for 
irrununoblotting. 
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Animal Inoculation 
Female Robertsonian [Rb(8 . 12 )] mice (Jackson Labs., Bar Harl:x:>r, 
MA) , 8-1 2 weeks old, were used for immunization. 12 The amount of M. 
bovis ATCC 19210 HKWC antigen and immunization schedule used for four 
different fusions are listed in Table 1. The concentration of inoculum 
used to immunize mice for fusion 01 was 10 mg M. l:x:>vis HKWC per ml PBS 
and 100 ul (1 mg) was given by intraperitoneal injection at 7-day 
intervals for six injections. Three days prior to fusion, an injection 
of 200 ul ( 2 mg) was given. A modified immunization schedule was 
adopted in fusion 02 . Mice were immunized as in fusion 01; then t he 
mice were injected with 5 mg HKWC at 55 days and with 15 mg HKWC at 62 
days {three days prior to fusion). In fusion 03 and 06 , mice were 
given intraperitoneal injections of 100 ul (5 mg) at 1 week intervals 
for six weeks using an inoculum containing 50 mg/ ml PBS . Three days 
pr i or to fusion, mice were inj ected with 200 ul M. l:x:>vis HKWC antigen 
adjusted to 75 mg/ ml PBS (15 mg ) . Inoculum used for injecting mice for 
fusion 01, 02, and 03 was from M. l:x:>vis grown on Middlebrook and Cohn 
medium containing OADC enrichment; inoculum used for fusion 06 was from 
cells grown on modified Middlebrook and Cohn base medium to which 
pyruvate , asparagine, glutamate, and dextrose were added. 
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TABLE 1. Inoculation schedules for mice ~iven 
heat killed Mycobacterium bovis 
Immunization Schedule 
Fusion 
Number Amount Day 
01 1 mg 0 
" 7 
II 14 
II 21 
II 28 
" 35 
2 mg 42 
02 1 mg 0 
II 7 
" 14 
II 21 
" 28 
II 35 
2 mg 42 
5 mg 55 
15 mg 62 
03, 06 5 mg 0 
II 7 
" 14 
II 21 
II 28 
II 35 
15 mg 42 
ainoculations given through 
intraperitoneal r oute . 
Hybridoma Production 
The mice were euthanatized and spleens were rerroved from mice 
aseptically, rinsed in sterile PBS, transferred to a petri dish 
containing 10 ml of sterile PBS, and minced to obtain separate spleen 
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cells . A single 10C>use was used for each fusion experiment. The spleen 
cell suspension was transferred t o a centrifuge tube and FOX- NY myeloma 
cells (Hyclone Labs., Logan, UT) were mixed at a ratio of 1:2, myeloma 
to spleen cells.12 The myeloma-spleen cell suspension was ce~trifuged 
at 300 rpm for 10 minutes; supernate was discarded, and 0 . 5 ml of 45% 
polyethylene g lycol 1540 (EM science , Gibbstown, NJ) in sterile PBS was 
mixed with the pellet. After 60 seconds at 37°c , the cell suspension 
was diluted with 20 ml of Dulbecco ' s Minimum Essential Medium10 (Gibco 
Ltd., Gr and Island, NY) (DMEM) . Then fused cell suspension was added 
t o DMEM containing 7 . 5xl0-5M adenine, 8xl0- 7M aminopterin, l.6xl 0- 5M 
thymidine, streptomycin sulfate (100 mg/ L) , penicillin (lxl05 units/ L) , 
and 15% horse serum (DMEM-AAT). 
One-third the number of cells from a spl een of a nonimmunized 
mouse and peritoneal macrophages (to approximately 250 cells per ml ) 
were added to the fused cell suspension in fusions 01 , 02 , and 03 . tor 
comparison (fusion 6) , approximately 1Xl08 FOX-NY myel oma cells were 
added to a fused cell s uspension . tusion suspensions were distributed 
into 96-well tissue culture plates (Cost ar, Cambr idge, MA) , and 
hybridoma cell cultures were incubated in a humid , 5% cn2 atmosphere at 
37°c. After 8 t o 10 days, hybridoma supernatants were screened for 
presence of antibody with activity t o !:!· bovis HKWC using an ELISA. 
Hybridoma col onies pr oducing antibody that detected M. bovis antigens 
were further maintained in 24-well culture plates using DMEM-AAT with 
amphotericin B (3 mg/L) (DMEM- AATt) and screened again for activity by 
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ELISA; the cells were recloned twice by limiting dilution with DMEM- AAT 
in 96-well plates. Single col onies corresponding t o supernatants with 
strong positive ELISA r eactions to .!:!· bovis were transferred t o 24- well 
2 plates. Cells were then trans ferred t o 25 cm tissue culture flasks 
containing OMEM-AATF. Al i quots of cells were suspended in DMEM 
containing 15% horse serum and 10% dimet hylsulfoxide (DMSO) and 
cryopreserved at - 7o0 c or in liquid nitrogen. 
Enzyme-Linked Immunosorbent Assay 
A modified ELISA procedure was used to screen hybridoma cell 
cultures13114 • Mycobacterium bovis ATCC 19210 HKWC antigen pr eparation 
(50 mg/ ml ) was used at a dilut ion of 100 ul (5 mg) in 5 . 0 ml 0 .1 M 
Na2co3 , pH 9 . 6 . The antigen solution was added t o Immulon I Dynatech 
microtiter plates (Dynatech , Alexandria , VA) at 50 ul per well followed 
by an equal volume of cyanamide 1 mg/ml 0. 1 M Na2co3 , pH 9 . 6 . Plates 
were incubated at 4°c for 16 hours, washed three times with PBS , pH 7 . 2 
and then 0 . 1 M NH4Cl (100 ul/ well ) was added and incubated at room 
temperature (RT) f or 30 minutes. The antigen coated plates were washed 
three times with phosphate buffer containing 0 . 5 M NaCl and 0 . 5% Tween 
80 , pH 7 . 5 (ELISA wash solution). For evaluating fusions 01 , 02 , and 
03 , hybridoma supernatants and negative controls (50 ul/ well) were 
incubated with shaking at RT for 1 hour. Negative controls included: 
1) DMEM- AATF , 2) conditioned medium from FOX-NY myeloma cell cultures 
(DMEM-CM) , and 3) 15% horse serum in phosphate buffer containing 0 . 5 M 
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NaCl and 1.0% Tween 80 , pH 7. 5 ( ELISA diluent) . Hybridoma 
supernatants from fusion 06 and negative controls were used at serial 
dilution 1:10 in diluent (50 ul/ well). Pl a t es were then washed eight 
times with ELISA wash solution and goat anti-mouse IgG (H+L) 
horseradish peroxidase conjugate antibody (Kirkegaard & Perry labs., 
Gaithersburg , MD) at a dilution of 1:500 in diluent, was added 50 
ul / well and the plates were incubated with shaking at RT for 1 hour . 
Plates were washed e i ght times with ELISA wash solution and briefly 
dried to remove excess fluid. Substrate- chromagen solution consisting 
of 0 .4% H2o2 , 2,2
1 -azino-d i-3-ethyl-benzthiazoline sulfonate (ABTS) in 
0 .05 M citric acid, pH 4.0 (100 ul/ well ) was added and absorbance at 
405 nm was recorded. The ELISA was used t o screen for ant ibody produced 
by recloned hybridoma cell cultures . 
Cell Culture Medium Comparison 
To determine effects of amphotericin B on hybridoma viability, 
selected col onies were maintained in cell culture using DMEM- AAT with 
or without amphotericin B. Hybridoma cell lines 33 through 47 had 
corresponding supernatants with anti-M. bovis activity as determined by 
ELISA after primary screening. The 15 colonies were transferred in 
duplicate from fusion plates t o tissue culture plates and cultured in 
DMEM-AAT or in DMEM-AAT containing amphotericin B (3 mg/L). Both sets 
of cell cultures were maintained for 12 days and cell viability was 
evaluated based on visual inspection. In addition, ELISA were 
conducted t o obtain information on antibody activity. 
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RESULTS 
Hybridoma Production 
The protocol for cell fusion and for maintaining cell cultures used 
in fusion 01 and 02 were similar; however, the irrmunization schedules 
varied. The nurrber of wells containing hybridoma colonies and 
supernatants with antibody activity to M. bovis HKWC as determined by 
ELISA are listed in Table 2. In fusion 01 , 14 of 110 colonies 
TABLE 2 . Number of hybr idoma colonies and 
supernatants containing antibody to 
MyCobacterium bovis obtained after fusion 
experiments 
Wells # Colonies at Day Number 
Fusion Seeded positive a % positive 
01 768 110 14 14 13 
197 23 28 14 
02 1152 93 17 32 34 
113 22 47 42 
142 37 64 45 
aSupernatants with ELISA value greater than twice 
the optical density value of the negative control. 
at day 14 had supernatant with antibody activity to M. bovis and at 23 
days incubation, 28 of 197 hybridoma colonies had supernatant wi t h 
antibody activity t o M. bovis. No additional colonies were obser ved 
after 23 days. 
In fusion 02 , 32 of 93 colonies at day 17 and 47 of 113 colonies 
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at day 22 had supernatants with antibody activity to M. bovis . A total 
of 64 of 142 colonies had supernatants with antibody activity to M. 
bovis at 37 days of cell culture. The number of positive supernatants 
per total number of colonies in fusion 02 was greater as compared to 
fusion 01. In fusion 02, the animal was inoculated at 55 and 62 days 
with 5 mg and 15 mg of cells, respectively. 
In fusion 06, approximately 90% of the wells contained colonies; 
however supernatants from only 182 colonies exhibited positive ELISA 
reactions at day 10 of culture. Mice used in fusions 02 and 06 had 
serum antibody titers greater than 1:320. The number of colonies 
obtained when FOX-NY myeloma cells were used as feeder cells (fusion 
06) was greater than in fusion 01 or fusion 02 where spleen cells and 
macrophages were used as feeder cells. 
Cell Culture Media Comparison 
Twelve of 15 hybridoma colonies increased in cell nunt>er and 
remained viable when DMEM-AATF was used and one cell line produced 
antibody with activity against M. bovis. Similar results were obtained 
using DMEM-AAT indicating that amphotericin B did not contribute to 
loss of cell viability. 
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Optimization of Enzyme-Linked Immunosorbent Assay 
Parameters of the ELISA were adjusted t o increase accuracy i n 
detection of stable hybridomas producing antibody against M. bovis ATCC 
19210. When the ratio of the test optical density {OD) value to the 
negative control OD value was equal t o or greater than 2, an ELISA 
reaction was considered positive. Negative controls consisted of PBS, 
DMEM- AATF, DMEM-CM , and horse serum diluted to 15% in ElISA diluent. 
Supernatants of 197 colonies (fusion 01 ) were positive on ELISA . 
Corresponding colonies were transferred t o 24 well culture plates, 
maintained, and viable cell lines were retested. Ratio of OD values 
were calculated at 5, 10, 20 , 30 , 40, and 60 minute time intervals 
(Figure 1 ) . Supernatants from 12 colonies were positive after 30 
minute of reaction time; this number did not change at 40 and 60 
minutes reaction time. Supernatants of two cell lines (numbers 1 and 
6) had OD r atios of 11 and 5 . 75 at 30 minutes , respectively. Antibody 
from cell line 6 was used as a positive control for evaluating 
s upernatants from subsequent fusions . 
Fusion 02 was screened at 17 , 21 , and 37 days. Reactions wer e 
considered positive when OD ratios approached positive control 6 OD 
ratio (7 . 0 times the negative control OD value). Sixty four of 142 
fusion supernatants screened had positive reactions; corresponding 
colonies were maintained in culture. Supernatants of viable cell lines 
were retested in an ELISA and ratios were cal culated using the test OD 
value divided by positive control OD value (Fi gure 2) . Supernatants 
FIGURE 1. Results of enzyme-linked inmunosorbent assay on supernatants 
of 28 hybridoma colonies (fusion 01) at various time 
intervals. Heat-killed Mycobacterium bovis 
(50 ug per well) was used as antigen. Monoclonal antibody 
binding was detected using goat anti-mouse IgG (H+L) 
peroxidase labeled antibody. Results are expressed as a 
ratio of optical density of test sample divided by 
optical density of negative control. Individual numbers 
represent hybridoma cell lines 
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from four cell lines (numbers 1, 27, 31, and 49 ) had OD values equal to 
or greater than the OD value of the i;:ositive control after 30 minutes 
and 60 minutes. The supernatants of four other cell lines (nunbers 2, 
34, 58, and 60) had OD ratios of 0.75 to 1.0. The eight cell lines 
with OD ratios greater than or equal to 0.75 remained viable and 
continued to produce antibody. Therefore, a ratio of 0.75 or greater 
was considered a positive reaction indicating production of McAb to M. 
bovis. 
Serial dilutions of supernatants from hybridoma colonies obtained 
from fusion 03 were evaluated using ELISA (Figure 3). A dilution of 
1:10 was optimal for screening fusion supernatants. Results of 
evaluation on three supernatants representing high, intermediate, and 
low antibody activity to M. bovis activity (A, B, and C), a i;:ositive 
control (cell line 6), and a negative control (media control; no colony 
present) were compared. At a 1:10 dilution, antibody activity to_!:!· 
bovis of supernatant C was similar to the negative control. The OD 
values of supernatant A and positive control supernatant also remained 
unchanged at this dilution. Supernatant C had intermediate antibody 
activity. Supernatants at serial dilution 1:10 were used in ELISA to 
screen fusion 06. 
FIGURE 3. Results of enzyme-linked irrununosorbent assays on three 
supernatants (fusion 03) as compared to positive and a 
negative control (A= high antibody activity to 
M. bovis, B= intermediate, and C= low antibody 
act1v1ty to M. bovis). Heat-killed 
Mycobacteriuili bov1s (50 ug per well) was used 
as antigen. Serial dilutions (50 ul) of fusion 
supernatants and control supernatants were used. 
Antibody binding was detected using goat anti-mouse 
IgG (H+L) peroxidase labeled antibody. Optical 
density was recorded at 30 minutes 
,,..--..... 
E 
c 
l.{) 
0 
"'1-
~ 
(f) 
z 
w 
0 
_J 
<( 
(_) 
I-
Q_ 
0 
1.600 
1.400 
1.200 
1.000 
0 .800 
6 _ 6 B 
o-o A • - • C 
• - • Pos Contro l 6 o-o Neg Contro l 
0 
0--- "" 0 1~-0---0--- "" ~
0 
o~ 
0 ·--··--·------- ·- ·- .-------- ·~ 
6 
0.600 --6---~ ·~ 
6-----6 • 0 .400 . -----.. _______ ~ 
o. 2 00 - 0 ...._____ .. _____ .. _____ .. ~==--------& =-=- -= L_~~_:::: ------::::::~01:==::~0~----::::::=:_o~----;;;;; ;~.:..;:.~~ ~====-;-~-~9 
0.000 0 1 2 3 4 5 6 
DILUTION (Log2 ) 
Ul 
0 
51 
DISCUSSION 
Comparison of fusion experiments 01 and 02 indicates that use of 
mice further inununized with 5 mg heat killed M. bovis ATCC 19210 at day 
55 and 15 mg at day 62 resulted in a greater number of supernatants 
with positive ELISA reactions. The use of an inoculum of 1 mg M. bovis 
may not have been adequate to ilTITiunize mice. The spleen of the mouse 
used in fusion 02 was larger than the spleen of the mouse used in 
fusion 01 suggesting improved immunization . Since about 90% of wet 
weight of bacterial cells is water, the number of remaining antigenic 
determinants may have been inadequate to stimulate a humeral response. 
The longer irrununization period for fusion 02 may also have influenced 
the efficiency of McAb production. Although the number of hybridoma 
colonies obtained after fusion 01 was slightly greater than the nunt>er 
obtained after fusion 02, the percentage of hybridomas producing 
antibody with activity to M. bovis was greater after fusion 01 . 
Antigen preparations used to produce McAb in other studies have 
included supernatant from sonicated M. bovis (50 ug), 9 M. tuberculosis 
whole cells (2Xl07 and 1Xl08 ), 5 bacterial press extract from M. 
tuberculosis (100 ug),11 and sonicated heat killed M. bovis (1 mg) in 
adjuvant8 • 
Production of larger numbers of hybridoma colonies allows 
selection of McAb to different determinants. For fusion 01 and 02 , 197 
colonies out of 768 wells seeded and 142 out of 1152 wells represents 
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26% and 12% of the total number of wells seeded that contain colonies. 
Normal spleen cells and macrophages from a nonirrmunized mouse were used 
as "feeder cells" in fusion 01 and 02. Approximately 90% of the seeded 
wells contained hybridoma colonies when FOX-NY myeloma cells where used 
as "feeder cells" in fusion 06. The increased nurrber of hybridomas 
generated after fusion 06 may have resulted from improved cell culture 
conditions through release of cellular components from "feeder" 
myelomas that enhance growth. Additional myeloma cells may have 
allowed for further fusing of spleen cells possessing cell membranes 
affected by PEG. Cell cultures supplemented with myeloma cells showed 
improved growth. Fusion experiments using mice inununized with whole 
cells or sonicate of M. tuberculosis, sonicate of M. leprae, or a 
sonicate of M. bovis have resulted in 90% to 100% hybridomas. 5 These 
findings are simular to those reported herein. Efficient myeloma-
spleen cell fusing techniques provide an increased population of 
hybridomas which is advantageous when producing McAb to numerous 
antigenic determinants. 
The ELISA allows rapid screening of hybridoma colonies and 
selection of hybridomas producing antibody to target antigen . 
Optimizing parameters in ELISA provided for accurate detection of 
antibody activity to antigens of heat-killed .!:!· bovis . This 
investigation indicates that conjugate antibody-substrate reaction time 
influences the distinction between antibody binding to M. bovis and 
nonspecific binding of mouse antibody and/or of conjugate. The number 
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of hybridoma supernatants with positive reactions (OD ratios equal to 
or greater than 2) did not increase after 30 minutes. A 30 minute time 
interval after initiation of enzyme-substrate reaction is considered 
adequate to allow detection of antibodies against M. bovis. High OD 
ratios indicate high levels of antibody, implying stable growth of 
hybridomas and antibody production. Hybridoma cell line 6 remained 
viable and supernatant containing VMB6 was used as a positive control 
in subsequent fusion experiments. The criteria of evaluating hybridoma 
supernatants by using VMB6 to calculate an OD ratio, with a positive 
reaction equal to or greater than 0.75, was considered acceptable. 
Ratios of OD values less than 0.75 indicate cell lines that loose the 
ability to produce antibody. 
To minimize growth of fungi in prolonged cell culture, culture 
media was supplemented with amphotericin B. Amphotericin B did not 
affect hybridoma viability when used at 3 mg/ml in DMEM-AAT as 
indicated by survival of 12 of 15 cell lines. Death of hybridomas upon 
transfer from fusion cultures may be due to other factors such as 
selection of unstable hybridomas or unfused B-cells. 
An attempt to improve efficiency of screening for McAb using ELISA 
was made to limit unnecessary selection and manipulation of numerous 
cell lines. The nunt>er of positive ELISA reactions were reduced by 
using a 1 to 10 dilution of supernatants from fusion cultures. 
Positive reactions, other than actual production of antibody from 
hybridomas, may result from initial production of antibody followed by 
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death of unstable hybridomas or residual antibody from unfused primed 
B-cells secreting antibody into the culture medium. In addition, newly 
formed hybridomas contain chromosomes from both parent cells and in 
early stages of hybridoma proliferation one complement of chromosomes 
can be lost7 ' 2• Loss of light chain synthesis corresponding to 
antibody from the B-cell can result in viable hybridomas producing McAb 
I 
that no longer exhibit binding activity for the target antigen. 
Dilution of fusion supernatant (1:10 with ELISA diluent ) reduced 
residual antibodies to levels so that negative OD ratios were obtained 
as compared to positive values for control VMB6 . 
Hybridomas secreting monoclonal antibodies with anti-M. bovis 
activity were produced and detected using methods described herein. 
Monoclonal antibodies produced to M. bovis can be used to identify 
antigenic determinants, and corresponding antigens detected can be 
investigated further for the ability to stimulate immune responces or 
for use in detecting exposure to M. bovis. 
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SECTION II. PRODUCTION AND PARTIAL CHARACTERIZATION OF MONOCLONAL 
ANTIBODIES TO VIRULENT Mycobacteriurn bovis 
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SUMMARY 
Monoclonal antibodies were produced to virulent ~· bovis ATCC 
19210 using a suspension of heat inactivated whole cells. Robertsonian 
(8.12) strain mice were given intraperitoneal injections at seven day 
intervals for six weeks. Hyperimmunized mice were boosted and spleen 
cells were fused with mouse FOX-NY myeloma cells. Hybridoma cell 
supernatants were screened for activity to the homologous strain of M. 
bovis using an enzyne-linked immunosorbent assay (ELISA). Heat-
inactivated M. bovis cells were bound to microtiter plates by wet 
binding overnight at 4°c. Six monoclonal antibodies where chosen for 
characterization. Immunoglobulin isotypes were IgGl for McAb VMB6, 
VMB73, and VMB93 and IgG2a for VMB31, VMB99, and VMB119 as determined 
by using isotype antisera. Monoclonal antibodies were examined for 
cross reactivity by using heat-inactivated M. tuberculosis, M. 
kansasii, M. fortuitum, M. paratuberculosis, M. avium serovars 1, 2, 4, 
8, and 10, M. chelonei, M. phlei, M. scrofulaceum, ~· smegrnatis, N. 
asteroides, and, R. equi. The six McAb could be grouped on the basis 
of binding activity in ELISA and immunoblot where VMB6, VMB31, and 
VMB119 exhibited binding activity limited to M. bovis; VMB93 and VMB99 
. -
detected M. bovis and M. tuberculosis antigens, and VMB73 reacted with 
other mycobacterial species as well as with N. asteroides, and R. equi. 
Apparent molecular weight of antigens are 30 to 25 kilo (k} for VMB6, 
VMB31, and VMB119, and 63 k for VMB93 and VMB99, and ranged from >200 
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to 31 k for VMB73 as estimated by immunoblot techniques. Monoclonal 
antibody binding activity to 18 field isolates of M. bovis, obtained 
from different animal species across the United States, was evaluated 
in ELISA. Each of the 18 field isolates were detected using VMB6, 
VMB31, or VMB119, ten of the isolates were detected by VMB93/VMB99, and 
minimal binding activity to 14 field isolates was exhibited by VMB73. 
The McAb failed to detect antigens from M. bovis strain AN-5 in ELISA. 
Mycobacterium bovis strain AN-5 is used in production of reference M. 
bovis purified protein derivative (PPD ) tuberculin utilized for testing 
cattle in the United States and several other countries. 
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INTRODUCTION 
In past years, researchers have attempted to develop serological 
diagnostic tests for tuberculosis in humans1 and in cattle. 20 Success 
in obtaining a reliable, sensitive, and convenient test system for 
cattle has been lirnited. 26 A common problem with serodiagnosis has 
been lack of specificity, occurring as negative results in infected 
animals or positive results in healthy animals. 5 Possible explanations 
for these observations could be the absence of hum::>ral response at 
certain stages of infection or, in regards to the serological assay, 
lack of purified specific antigens and use of polyclonal antisera that 
can not identify individual antigenic determinants am::>ng complex common 
antigens of mycobacteria. Preparation of purified antigens from 
mycobacteria with specific antigenic determinants would improve skin 
testing and ELISA for diagnosis of bovine tuberculosis. Monoclonal 
antibodies (McAb) have the characteristic of identifying a single 
antigenic determinant8 ; therefore, a species specific McAb would allow 
detection of the corresponding antigen of M. bovis. Thus, McAb make it 
possible to identify and isolate an antigen for use in serodiagnosis. 
Mycobacterium bovis is responsible for bovine tuberculosis18121 
and virulent M. bovis ATCC 19210 is the neotype strain.6 During the 
process of infection, antibodies are produced by the host animal and 
are directed against antigenic determinants of M. bovis. 22123 This 
polyspecific antisera can be associated with the degree of exposure of 
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an animal to M. bovis . High antibody titers to ~· bovis indicates 
exposure . Antigen with a specific determinant of M. bovis and the 
corresponding specific antibody can be used in assays to quantitate the 
level of anti~ies in sera of animals in attempt to predict infection . 
This could result in greater sensitivity and an ability to detect 
antibodies in the early course of mycobacterial infection . 
The objectives of this investigation were to a) pr-oduce McAb to 
virulent M. bovis ATCC 19210, b ) determine isotype of McAb, c) obtain 
information on the binding activity of McAb by using different species 
of mycobacteria , d) estimate molecular mass of corresponding antigens, 
and e) use of McAb in comparing field isolates of M. bovis . 
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MATERIALS AND METHODS 
Bacteria 
Mycobacterium bovis ATCC 19210, M. tuberculosis ATCC 27294 
(H37Rv) , and M. paratuberculosis ATCC 19698 are neotype strains and 
were obtained from the American Type Culture Collection. Mycobacterium 
avium compl ex (serovars 1, 2, 4, 8, and 10), M. chelonei, M. fortuitum, 
!:!.· kansasii, M. phlei, M. scrofulaceum, M. smegmatis, and 21 M. bovis 
field isolates were obtained from the National Veterinary Services 
Laboratories, U. S. Department of Agriculture , Ames, IA. The 
geographical location and species origin of the !:!· bovis isolates are 
listed in Table 1. Mycobacterium bovis strain AN-5, M. bovis sex; 
strain Pasteur, Nocardia asteroides , and Rhodococcus equi were obtained 
from the Department of Veterinary Microbiology and Preventive Medicine 
culture collection, College of Veterinary Medicine, Ames, IA. 
Organisms were subcultured on Middlebrook & Cohn 7Hl0 agar base 
medium10 (BBL Microbiology Systems , Cockeysville , MD) with pyruvate 
(8.2 g/L), L-asparagine (5 . 0 g/L), L-glutamic acid (6.0 g/L), and 
dextrose (30 g/L) with incubation at 37°c . 
Antigen Preparation 
Cells were harvested after 6 to 8 weeks incubation and washed 
twice by resuspension in sterile , deionized, and distilled H
2
o and by 
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TABLE 1. Isolate number, geographic location, and species 
of origin for 21 M. bovis field isolates 
Isolate nunt>er State Species of Origin 
1 TX Antilocapra 
2 NY Wisent 
3 MD Antilocapra 
4 TX Bovine 
5 NC Bovine 
6 NM Bovine 
7 HI Porcine 
8 HI Porcine 
9 KS Bovine 
10 LA Bovine 
11 TX Bovine 
12 IA Bovine 
13 VA Bovine 
14 NE Bovine 
15 TX Bovine 
16 CA Bovine 
17 CA Bovine 
18 NC Bovine 
19 HI Porcine 
20 OH Bovine 
21 SD Bison 
centrifugation at 10,000 rpm. The resulting pellet was weighed, 
resuspended in sterile phosphate buffered saline (PBS) to a cell 
suspension of 50 mg/ml (wet weight), and autoclaved for 10 minutes at 
121°c. Antigens were prepared by the above method for all bacterial 
species, except R. equi which was not heat-killed, and stored at -20°c. 
The heat killed whole cell (HKWC) antigen was used for immunizing mice, 
ELISA evaluations, and in immunoblot procedures. 
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Immunization and Hybridoma Production 
Female Robertsonian (8.12) 5 Bnr [Rb(8.12) mouse] mice17 (Jackson 
Labs, Bar Harbor, MA) 8 to 12 weeks old were immunized on a schedule of 
100 ul (5 mg) of HKWC ~- bovis antigen given by intraperitoneal 
injection at one-week intervals for a total of 6 injections. Three 
days prior to fusion, mice where boosted with 200 ul (15 mg) HKWC M. 
bovis antigen adjusted to 75 mg/ml PBS. 
Spleens from boosted mice were aseptically reroc>ved, rinsed in 
sterile PBS, transferred to a petri dish containing 10 ml of sterile 
PBS, and minced to obtain separate spleen cells. The spleen cell 
suspension was transferred to a centrifuged tube and FOX-NY myeloma 
cells (Hyclone Labs, Logan, UT) were mixed in at a ratio of 1:2, 
myeloma to spleen cell.17 The myeloma/spleen cell suspension was 
centrifuged at 300 rpm for 10 minutes, supernate was discarded, and 0.5 
ml of 45% polyethylene glycol 1540 (EM science, Gibbstown, NY) in 
sterile PBS was added. Fusion was allowed for 60 seconds at 37°c, and 
then the pellet was diluted in 20 ml of Dulbecco's Minimum Essential 
Medium15 (Gibco Ltd., Grand Island, NY) (DMEM). To select for myeloma-
B lymphocyte hybrids, the fused cell suspension was added to DMEM 
containing 7.5xl0-5M adenine, 8xl0-7M aminopterin, l.6xl0-5M thyrnidine, 
streptomycin sulfate (100 mg/L), penicillin (lx105 units/L), and 15% 
horse serum (DMEM-AAT), and distributed into 96-well tissue culture 
plates (Costar, Cambridge, MA). Hybridoma cell cultures were incubated 
in a humid, 5% co2 atmosphere at 37°c. After 8 to 10 days, hybridoma 
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supernatants were screened for the presence of antibJdy with activity 
to M. bovis HKWC using an ELISA. Hybridoma colonies producing antibJdy 
that detected M. bovis antigens were transferred to 24-well plates 
(Costar, Cambridge, MA), screened again for p::>sitive activity, and 
recloned twice by limiting dilution in 96-well plates using DME21-AAT 
with amphotericin B added 3 rng/L (DMEM-AATF). Single colonies, 
corresp::>nding to supernatants with strong p::>sitive ELISA reactions to 
M. bovis, were transferred to 24-well plates, then to 25 cm2 tissue 
culture flasks (Costar, Cambridge, MA), and maintained in cell culture 
using DMEM-AATF. Aliquotes were cryopreserved at -70 C and in liquid 
nitrogen by using DMEM containing 15% horse serum and 10% 
dimethylsulfoxide (DMSO). 
Enzyme-Linked Immunosorbent Assay 
A rrodified ELISA was used to detect McAb in supernatant from 
hybridoma colonies. 19120 Mycobacterium bovis ATCC 19210 HKWC antigen 
was used for hybridoma supernatant screening at a dilution of 100 ul (5 
m::J) in 5.0 ml 0.1 M Na2co3 , pH 9.6. The antigen solution (50 ul per 
well) followed by cyanamide 1 mg/ml 0.1 M Na2co3, pH 9.6 (50 ul per 
well) were added to Imrnulon I microtiter plates (Dynatech, Alexandria, 
VA). Plates were incubated at 4°c for 16 hours, and washed three times 
with PBS pH 7.2 prior to addition of 0.1 M NH4c1 (100 ul per well) and 
incubation at room temperature (RT) for 30 minutes. The antigen-coated 
plates were then washed three times with phosphate buffer containing 
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O.S M NaCl and 0.5% Tween SO, pH 7.5 (ELISA wash). Hybridoma 
supernatant and negative control samples at a serial dilution of 1:10 
in phosphate buffer containing 0.5 M NaCl and 1.0% Tween SO, pH 7.5 
(diluent) was added (50 ul per well) and incubated with shaking at RT 
for 1 hour. Negative controls included DMEM-AATF, conditioned medium 
from FOX-NY myeloma cell cultures (DMEM-CM), and horse serum diluted t o 
15% in diluent. The plates were then washed eight times with ELISA 
wash and goat anti-mouse IgG (H+L) horseradish peroxidase conjugate 
antibody (Kirkegaard & Perry Labs, Gaithersburg, MD), at a serial 
dilution of 1:500 in diluent, was added (SO ul per well) followed by 
incubation with shaking at RT for 1 hour. Plates were washed eight 
times with ELISA wash and briefly dried to reroc>ve excess fluid. 
Substrate/chrornagen solution consisting of 0.4% H2o2 , and 2,2'-azino-
di-3-ethyl-benzthiazoline sulfonate (ABTS) in 0.05 M citric acid, pH 
4.0 was added (100 ul per well) and absorbance at 405 nm was measured 
after 30 and 60 minutes. 
Monoclonal antibody binding activity towards other mycobacteria, 
non-mycobacterial species, and field isolates of M. bovis were also 
evaluated by using ELISA. Each antigen preparation from mycobacterial 
and non-rnycobacterial species was used to coat Immulon I microtiter 
plates. Supernatants from hybridomas producing antibody that detected 
M. bovis antigens were tested for specificity of antibody activity 
using the modified ELISA procedure as described above. 
Isotype identification of McAb was determined using an ELISA 
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procedure as instructed by manufacturer in a Mouse Irrununoglobulin 
Subtype Identification Kit (BMB, Indianapolis, IN) . Briefly, M. bovis 
HKWC was used as antigen in microtiter plates followed by incubation 
with supernatant from VMB hybridoma cultures diluted 1 in 5 with ELISA 
diluent. Rabbit anti-mouse lg of subclass specifies IgA (o<.) , IgG1 (o 
1), IgG2a (f 2a), IgG2b Ct 2b), IgG3 (f 3), and IgM (p ) were used to 
detect antigen-VMS complexes. Peroxidase- labeled goat anti-rabbit IgG 
was used to detect specific rabbit anti-mouse lg antibody as i ndicated 
by reactions after adding a solution of ABTS . 
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SOS- PAGE ) 
and Inununoblot 
A SOS-PAGE procedure11 was modified in which a 6 to 20% linear 
gradient resolving gel and 4% stacking gel was used with a 
discontinuous buffer system in SOS-PAGE . Samples were prepared for 
electrophoresis by resuspending a 5 mg pellet of HKWC antigen i n 60 ul 
of 63 mM TRIS-HCl buffer, pH 6 .8 containing SOS (3% ) , dithiothreitol 
(1%) , and br omophenol blue (0. 01%) . 1 Prestained molecular weight 
standards (BRL, Gaithersburg , MD) were also included. After heating 
the samples at 95°c for 20 minutes, insoluble material was removed by 
brief centrifugation at 14,000 rpm, and supernate was electrophoresed 
at 50 volts per gel constant voltage overnight . Polyacrylamide gels 
containing resolved components were transferred to nitrocellulose (NC ) 
for use in immunoblotting experiments . 
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Resolved components were transferred t o NC sheets24 and detected 
by m:xlif ied immunoblot techniques. Electrophoretic transfer from the 
polyacrylamide gel to NC was performed in 25 mM phosphate buffer, pH 
7.5. Resolved components bound to NC were stained with colloidal gold 
total protein stain (Bio-Rad, Richman CA) 16 as described by 
manufacturers instructions or analyzed by McAb . The NC with bound 
resolved components was blocked using 0 . 01 M TRIS buffer, pH 7. 4 
containing Tween 20 (0.05%), 0 .15 M NaCl, and non-fat dry milk3 (5%) 
(TTS-MILK) for 1 hour. The blocked NC was i ncubated with McAb at a 
serial dilution of 1:20 or 1:100 in TTS-MILK buffer , washed in TTS- MILK 
buffer, and incubated with goat anti-mouse IgG (H+L) antibody 
conjugated with horseradish peroxidase diluted 1:1000 in TTS-MILK 
buf~r. Detected antigen-antibody complexes bound to NC were 
visualized after washing in TTS-MILK buffer and development wi th 4-
chloro- 1-napthol (0 . 05%) in methanol-TRIS-saline buffer containing H2o2 
(0 . 018%) . Irrmunoblots were performed using M. bovis antigens and 
heterologous antigen preparations from other mycobacteria and non-
mycobacterial species to estimate the molecular mass of antigenic 
components corresponding to McAb , and to detect cross reactions. 
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RESULTS 
Monoclonal Antibodies 
The number of wells containing supernatant with antibody against 
M. bovis, as determined by ELISA, are listed in Table 2. Out of 1152 
wells seeded after the fusion experiment, approximately 90% of the 
TABLE 2. Antibody activity to Mycobacteriurn 
bovis HKWC 10 days after fusion 
Number of 
Colonies a 
1032 
Number of Antibody 
Positive Wells 
182 
% 
18 
aTotal nurrber of wells seeded was 1152. 
wells contained hybridoma colonies. Each hybridoma supernatant 
containing VMB6 and VMB31 (obtained in preliminary f usion experiment s ) 
having ELISA reactions to M. bovis and not other species tested were 
used as positive controls for screening supernatants from fusion 
cultures. The OD values for positive controls were 6.75 (VMB6) times 
greater and 9.0 (VMB31) times greater than negative control values. As 
compared to control VMB6, 587 positive ELISA reactions were observed, 
where as compared to control VMB31, 182 (18% of 1032) of the 
supernatants were positive for antibody activity to antigens of M. 
bovis. Hybridoma colonies of supernatants with positive ELISA 
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reactions as compared to positive control VMB31 were cloned and 
recloned. Antibody titrat ion curves for supernatants from recloned 
hybridoma cell lines 6 , 31, 73 , 93 , 99 , and 119 are illustrated in 
Figure 1, and endpoint t i ters were 10, 100 , 20, 10, 8, and 500 
respectively. The immunoglobulin isotype of McAb VMB6, VMB73, and 
VMB93 were IgGl and VMB31, VMB99 , and VMB119 were IgG2a. 
ELISA 
Supernatant from recloned hybridoma cell cultures was tested for 
antibody activity to homologous !:!· bovis antigen and t o heterologous 
HKWC antigens from various species of mycobacteria us i ng an ELISA. 
Taxonomic binding patterns are summarized in Table 3. In using six 
McAb with ant ibody activity to M. bovis activity, VMB6, VMB31, and 
VMB119 detected M. bovis antigens, c r oss reactivity by VMB93 and VMB99 
was limited t o M. tuberculosis, and VMB73 exhibited non-specific 
binding activity. Binding activity of VMB73 was greater towards M. 
tuberculosis than towards the homologous antigen used in hybridoma 
production. Use of VMB73 also exhibited moderate binding activity 
towards M. kansasii, M. fortuitum, and!'!_· asteroides and weak binding 
activity towards M. aviurn serovars l and 10, M. paratuberculosis, M. 
phlei, M. smegmatis, and R. equi. 
Figure 1. Titration curves for each of 6 monoclonal antibodies as 
determined using an enzyme-linked immunosorbent assay. 
Mycobacterium bovis heat-killed whole antigen at 50 ug 
per well was used as antigen and monoclonal antibody 
binding was detected by goat anti-mouse IgG (H+L) 
peroxidase-labeled antibody. Optical density was recorded 
at 30 minutes of enzyme-substrate reaction time and optical 
density values are expressed as ·a mean of three 
determinations 
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~able 3 . Enzyme- l i nked immunosor bent assay reactions of 6 
monoclonal antibodies with 14 species of mycobacteria 
a nd with Nocardia aster o i des or Rhodococcus equi 
Monocl onal Antibody 
Species 
VMB6 'IMB31 V"'IB73 v,\1893 '/:vJB99 "[;·18119 
M. bovis 4 .9 la 6 . 22 2 . 53 6 . 45 6 . 53 6 . 10 
M. tuberculosis 1.99 8 . 45 2 . 54 3 . 20 2 . 11 
M. kansasii 4 . 31 
n. fortuitum 4 .02 
M. paratuberculosis 2. 78 
:-1. avium serovar l 1.86 
M. avium ser:-ovar 2 
M. avium serovar 4 
M. avium serovar 8 
M. avium ser:-ovar 10 2 . 14 
~1 . chelonei 
M. phlei 2 . 90 
M. scrof ulaceum 
M. smegmatis 2 . 55 
N. asteroides 4 . 70 
R. equi 2 . 07 
aReactions are expr essed as an opt i cal density ratio of test 
s ample optical dens ity value to negative control optical density 
value. Optical dens ity r atios equal to or less than 1 . 50 are 
indicated by -
Supernatants containing Mc Ab were also tested in ELISA using HKvlC 
from 18 fi e ld isol ates of M. bovis and three r:-eference strains o f M. 
bovis. Binding activity results are lis ted in Tabl e 4 . Use of Vtl86 , 
VMB31 , and VMB119 exhibited positive binding activity towards each of 
18 field isolates . Antigen from 10 o f the i solates was detected using 
VMB93 and VMB99 . Use of VMB73 detected antigen fr-om 14 isolates with a 
74 
binding pattern similar to VMB93 and VMB99 binding patterns, although 
overall binding activity was weaker. None of these six McAb detected 
antigen from M. bovis strain AN-5 and only VMB73 had minimal binding 
activity to M. bovis sex; strain Pasteur . 
Table 4. Enzyme-linked immunosorbent assay reactions of 6 
monoclonal antibodies with 18 field isolates of 
Mycobacterium bovis and three reference strains 
Monoclonal Antibody 
M. bovis 
VMB6 VMB31 VMB119 VMB93 VMB99 VMB73 
ATCC 19210 4.9la 6.22 6.10 6.45 6 .53 2. 53 
u 6.91 8.45 8 . 64 4.92 5.75 3 . 50 
#2 8.02 8 .47 12.98 2.47 3. 02 3.75 
#3 4.92 7.30 7.16 2.11 
#4 5.80 8.11 8 .13 1.69 2. 28 3.03 
#5 6.42 5.47 6.01 
#6 3 . 62 5 . 00 5. 23 
#7 8.19 9 .88 7 .90 7.28 9.85 2.89 
#8 7.82 9.19 7 . 79 3.80 4 .83 2.20 
#9 5.63 8.69 6 . 71 2.62 
Ul 3.82 5.07 3 .88 1.86 
#12 7.14 8 . 41 6 . 62 7.09 8.19 2.64 
#13 2.83 3.93 2. 41 
#14 4.21 6.38 5 . 40 1.74 
us 2.74 3.44 4 . 15 
#17 5.36 5 .49 7 . 13 1.74 2.15 2.13 
#19 3. 98 3.99 4 .42 3 . 06 3.83 2. 57 
#20 4.77 4.88 6.86 3.76 6 . 01 2.46 
#21 7.90 8 .18 9 . 22 5 . 35 7. 14 2.4 
AN-5 
Pasteur 1.95 
aReactions are expressed as an optical density ratio of test 
sample optical density value to negative control optical density 
value. Optical density ratios less than 1.50 are indicated by -. 
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SOS- PAGE and Imrnunoblot 
lycobacterial HKViC antigens and non- mycobacterial antigens were 
heated in the presence of SOS under r educing conditions, separated by 
polyacrylamide gel electrophor esis , and transferred t o NC sheets as 
descr ibed above . Bacterial components bound to NC were stained fo r 
total pr otein (f igur e 2) . riolecular we i gh t standar ds consisted of 
myosin (H- chain ) , phosphor ylase B, bovine serum albumi n , ovalbumin , a-
chymotrypsinogen , 8- lactogl obulin and lysozyme with apparent molecular 
weight 197 ,000 , 104 ,000 , 72 , 200 , 44 ,800 , 23 ,400 , 18 , 000 , and l~ , 600 , 
respectively . 
The NC bound M. bov is antigens wer e analyzed using V'.'·186 , '/MBJl , 
VMB73 , VMB93 , VMB99 , and VMBll9 (f igure 3) . VMB6 detected a ma jor 
antigenic component with an apparent molecula r weight in the r ange 
appr oximatel y 30 to 25 kilo (k) and faint s mears wer e also visible at 
appr oximately 54 k a nd 17 k . Similarly , V'-1831 and VMB119 det ected 
antigenic components in a range of 30 k t o 25 k . Smearing was also 
visible a t 55 k and 18 k after detection with Vi"1331 and at 55 k and 17 
k with VMB119 . One antigenic component was detec ted by each V~1B93 and 
V'IB99 having molecular weight of 63 k . ~·Jeak smear ing was visible at 
appr oximately 200 k t o 31 k when VMB73 was used t o de t ect NC bound 
antigens . 
Nitrocellulose bound components from mycobacter ia other than M. 
bovis were also anal yzed using each McAb . Use of VMB6 , V.·1831 , and 
FIGURE 2. Protein analysis of bacterial components. 
Bacterial components from heat-killed whole cells were 
separated by sodium dodecylsulfate-polyacrylamide gel 
electrophoresis and transferred to nitrocellulose. 
Protein was detected by colloidal gold total protein stain. 
Lanes: A, prestained molecular weight standards; 
B, M. bovis; 
c, M. tuberculosis; 
D, M. kansasii; 
E, M. fortuitum; 
F, M. ~ratuberculosis; 
G, M. I l; avium serovar 
H, M. avium serovar 2; 
I, M. avium serovar 4; 
J, M. avium serovar 8; 
K, M. avium serovar 10; 
L, M. chelonei; 
M, M. phlei; 
N, M. scrofulaceum; 
o, "M. scrofulaceum; 
p, M. scrofulaceum; 
Q, M. sm~matis; 
R, N. asteroides; 
s , 'R. equi 
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FIGURE 3. Immunoblot for each of six monoclonal antibodies using 
Mycobacterium bovis heat-killed whole cell antigen. 
Culture supernatants containing monoclonal antibody were 
used and antibody reactivity was detected using goat 
anti-mouse IgG (H+L) peroxidase-labeled antibody. 
Lanes: A, prestained molecular weight standards; 
B, VMB6 (1:100); 
C, VMB31 (1:100); 
D, VMB119 (1:100); 
E, VMB93 (1:20); 
F, VMB99 (1:20); 
G, VMB73 (1:20) 
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VMB119 de tected antigens from~· kansasii (F igm·es 4, 5 , and 6) , and 
Vi'-1893 and VMB99 detected~· tuber culosis antigens (Figur es 7 and 8) . 
VMB73 detected antigens from ~· tuberculosis, 1'1 . kansasii, M. 
fortui tum, M. par atuberculosis , M. avium serovar s 1 and 10 , i'l . 
smegmatis, N. asteroides , and~· equi (F i gure 9) . Appar ent molecul ar 
we i ght of antigenic comp::inents detected by use of Mc Ab with binding 
activi t y to ~· bovis are summarized in Tabl e 4 . VMB6 , VMB31, and 
VMB119 faintly de t ected M. kansasii comp::inents with molecular weight 34 
k , 32 k , and 31 k respectively . VMB9 3 and VMB99 each de t ected a 
comp::inent from ~· tuberculosis hav ing mol ecular weight 58 k with 
smearing fa intly vi sibl e at approximat el y 49 k . Molecular weight of 
antigens de tected by use of VMB73 were greater than 200 k, 65 k , 49 k, 
43 k, 38 k, 32 k, 29 k, 25 k and 18 k from M. tuberculosis , and 65 k 
and 22 k f r om M. kansasii. VMB7 3 also detected M. fortu itum antigens 
with molecular weight 65 k , 53 k , 48 k , 42 k, 37 k , 25k , and 15 k . A 
72 k ant i gen from ~· par a t ubercul osis and M. avium serovar 1 was 
detected by use of VMB73 as well as a 19 k comp::inent from M. avium 
ser ovar 10 . Comp::ine nts from~· smegmatis , detected by use of VMB73 , 
had mol ecul ar weight of 25 k , 17 k, and 13 k . V~1873 a lso detected 
numerous ant i genic compone nts f r om N. asteroides with molecul ar weight 
ranging from 65 k t o 10 k , and a singl e R. equi component of 65 k . 
FIGURE 4. Immunoblot analysis of bacterial components using VMB6. 
Bacterial components from heat-killed whole cells were 
separated by sodium dodecylsulfate-polyacrylarnide 
gel electrophoresis and transferred to nitrocellulose. 
Culture supernatant containing monoclonal antibody was 
used and antibody reactivity was detected using goat 
anti-mouse IgG (H+L) peroxidase-labeled antibody. 
Molecular weight (k) of antigenic components are 
indicated in lane space. 
Lanes: A, prestained molecular weight standards: 
B, M. bovis: 
c, M. tuberculosis: 
o, M. kansasii: 
E, M. fortuitum: 
F, M. paratuberculosis: 
G, 
H, 
I, 
J, 
K, 
L, 
M, 
N, 
o, 
p, 
Q, 
R, 
s, 
M. 
M". 
'M. 
M. 
M. 
'M. 
M. 
M. 
M. 
M. 
M. 
N. 
R. 
avium serovar 1: 
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avium serovar 4: 
avium serovar 8: 
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cheionei: 
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scrofulaceum: 
scro!uiaceum: 
scrofulaceum: 
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equi 
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FIGURE 5. Inununoblot analysis of bacterial component s using VMB31 . 
Bacterial components from heat- killed whole cells were 
separated by sodium dodecylsulfate-polyacrylamide 
gel electrophoresis and t ransferred to nitrocellulose . 
culture supernatant containing monoclonal antibody was 
used and antibody reactivity was detected using goat 
anti-mouse IgG (H+L) peroxidase-labeled antibody . 
Molecular weight (k) of antigenic components are 
indicated in lane space. 
Lanes: A, prestained molecular weight standards; 
B, M. bovis; 
c, M. tuberculosis; 
o, M. kansas11; 
E, M. fortuitum; 
F, M. paratuberculosis; 
G, M. av1um serovar l; 
H, M. avium serovar 2; 
r, M. av1um serovar 4; 
J, M. av1um serovar 8 ; 
K, M. 
L, M. 
M, M. 
N, M. 
O, M. 
p, M. 
Q , M. 
R, N. 
S , R. 
av1um serovar 
chelonei ; 
phle1; 
scrofulaceum; 
scrofulaceum; 
scrofulaceum; 
smegmatis ; 
asteroi des ; 
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FIGURE 6. Irranunoblot analysis of bacterial components using VMB119. 
Bacterial components from heat-killed whole cells were 
separated by sodium dodecylsulfate-polyacrylamide 
gel electrophoresis and transferred to nitrocellulose. 
Culture supernatant containing monoclonal antibody was 
used and antibody reactivity was detected using goat 
anti- rcouse IgG (H+L) peroxidase-labeled antibody. 
Molecular weight (k) of antigenic components are 
indicated in lane space. 
Lanes: A, prestained molecular weight standards; 
B, M. bovis; 
c, M. tuberculosis; 
D, M. kansas11; 
E, M. fortu1tum; 
F, M. paratuberculosis; 
G, M. av1um serovar l; 
H, M. av1um serovar 2; 
I, M. av1um serovar 4; 
J, M. avium serovar 8; 
K, M. av1um serovar 10; 
L, M. chelonei; 
M, M. phlei; 
N, M. scrofulaceum; 
o, M. scrofUlaceum; 
p, M. scrofulaceum; 
Q, M. smegmat1s; 
R, N. asteroides; 
S, R. equ1 
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FIGURE 7. Immunoblot analysis of bacterial components using VMB93. 
Bacterial components from heat-killed whole cells were 
separated by sodium dodecylsulfate-polyacrylarnide 
gel electrophoresis and transferred to nitrocellulose. 
Culture supernatant containing monoclonal antibody was 
used and antibody reactivity was detected using goat 
anti-mouse IgG (H+L) peroxidase-labeled antibody. 
Molecular weight (k) of antigenic components are 
indicated in lane space. 
Lanes: A, prestained molecular weight standards; 
B, M. bovis; 
c, M. tuberculosis; 
o, M. k.ansas11; 
E, M. fortu1turn; 
F, M. paratuberculosis; 
G, M. av1um serovar l; 
H, M. av1um serovar 2; 
r, M. av1urn serovar 4; 
J, M. av1urn serovar 8; 
K, M. aviurn serovar 10; 
L, M. chelonei; 
M, M. 2hlei; 
N, M. scrofulaceurn; 
o, M. scroluiaceum; 
p, M. scrofulaceurn; 
Q, M. smegmat1s; 
R, N. asteroides; 
s, R. equ1 
Sl:t0d0NW1)1rIH0.:1300 ev 
...... 
as 
L&i 
83 
FIGURE 8. Immunoblot analysis of bacterial components using VMB99. 
Bacterial components from heat-killed whole cells were 
separated by sodium dodecylsulfate-polyacrylamide 
gel electrophoresis and transferred to nitrocellulose. 
Culture supernatant containing monoclonal antibody was 
used and antibody reactivity was detected using goat 
anti-mouse IgG (H+L) peroxidase-labeled antibody. 
Molecular weight (k) of antigenic components are 
indicated in lane space. 
Lanes: A, prestained molecular weight standards: 
B, M. bovis: 
c, M. tuberculosis: 
D, M. kansas11.: 
E, M. fortuitum: 
F, M. paratuberculosis: 
G, M. avium serovar 1: 
H, M. 
r, M. 
J, M. 
K, M. 
L, M. 
M, M. 
N, M. 
o, M. 
P, M. 
Q, M. 
R, N. 
s, R. 
avium serovar 2: 
avium serovar 4: 
avium serovar 8: 
avium serovar 10: 
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FIGURE 9. Irrmunoblot analysis of bacterial components using VMB73 . 
Bacterial components from heat-killed whole cells were 
separated by sodium dodecylsulfate-polyacrylamide 
gel electrophoresis and transferred to nitrocellulose . 
Culture supernatant containing monoclonal antibody was 
used and antibody reactivity was detected using goat 
anti-mouse IgG (H+L) peroxidase-labeled antibody. 
Molecular weight (k) of antigenic components are 
indicated in lane space. 
Lanes: A, prestained molecular weight standards; 
B, M. bovis; 
c, M. tuberculosis; 
o, M. kansas11; 
E, M. fortul.tum; 
F, M. paratuberculosis; 
G, M. av1um serovar l; 
H, M. avium serovar 2; 
r, M. av1um serovar 4; 
J , M. av1um serovar 8; 
K, M. av1um serovar 10; 
L, M. chelonei; 
M, M. phle1; 
N, M. scrofulaceum; 
o, M. scrofulaceum; 
p, M. scrofulaceum; 
Q, M. smegmat1s; 
R, 'N. asterol.des; 
s, R. equi 
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TABLE 5. Estimated molecular weight of corresponding antigenic components for each of 
six Mycobacterium bovis monoclonal antibodies 
Monoclonal Antibody 
Antigen 
VMB6 VMB31 VMB119 VMB93 VMB99 
M. bovis 30-25a 30-26 30-25 63 63 
M. tuberculosis 58 58 
M. kansas11 34 32 31 
M. fortu1tum 
M. paratuberculosis 
M. avium serovar 1 
M. av1um serovar 10 
M. smegmatis . 
N. astero1des 
R. equi 
a Molecular weight values expressed in kilo. 
VMB73 
>200-3l(smear) 
>200,65,49,43,38,32,29,25,18 
65,22 
65,53,48,42,37,25,15 
72 
72 
19 
25, l 7 ,13 
65,54,42,37,31,28,20 
16-lO(multiple bands) 
65 
\0 
w 
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DISCUSSION 
Stringent criteria in designating positive hybridomas was adopted 
as elevated ELISA OD values may be considered a measure of anti-M. 
bovis activity implying stable cell line growth and antibody 
production. Supernatants from hybridoma cell lines 73 , 93, 99, and 119 
had the greatest activity in ELISA. VMB73, VMB93, VMB99 , and VMB119 
along with VMB6 and VMB31 were characterized by identifying 
immunoglobulin isotype, by determining cross reactivity t o other 
bacteria using ELISA and immunoblot, and by estimating apparent 
molecular mass of corresponding antigens. 
Stock supernatants containing VMB6, VMB31, VMB73, VMB93 , VMB99 , 
and VMB119 were diluted t o end point titers in an attempt t o adjust 
McAb t o equal concentrations with respect to M. bovis binding activity 
in ELISA. The six McAb were placed in three gr oups based on results of 
binding activity in ELISA and immunoblot. In ELISA , VMB6 , VMB31, and 
VMB119 exhibited binding activity limited t o M. bovis, VMB93 and VMB99 
detected antigens of M. tuberculosis and k!.· bovis, where as VMB73 cross 
reacted with other mycobacterial species, ~· asteroides, and ~· equi. 
In addition to antigens of M. bovis, antigen from M. kansasii was 
detected in minor amount by VMB6, VMB31, and VMB119, as indicated by a 
faint band on immunoblots. Detection of antigens of M. kansasii by 
VMB6 , VMB31, and VMB119 in immunoblot analysis and not in ELISA may be 
related to increased sensitivity in detecting NC bound antigens, steric 
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hindrance due to antigen binding to polystyrene plates, and/ or 
unmasking effects of the determinant by SOS in western blotting. 
Antigens of M. kansasii detected by VMB6 , VMB31 , and VMB119 appeared to 
have an apparent nolecular weight of 32 k. Other McAb produced with 
binding activity to M. tuberculosis have also detected antigens of M. 
bovis and M. kansasii. 219113 The finding that VMB6, VMB31, and VMB119 
identify antigens of M. kansasii provides additional evidence that 
shared determinants exist between M. kansasii and M. tuberculosis 
complex. 
The apparent MW of antigenic component(s) from M. bovis as 
visualized in imnunoblots using VMB6, VMB31, and VMB119 revealed 
antigens of 25 k and 30 k or a single 27 k antigen. Broad staining 
bands and smearing within lanes after immunoblotting indicates non-
protein components. Although VMB6, VMB31, VMB119 identify M. bovis 
antigens having the same apparent molecular weight, the same 
determinant may not be recognized. Since VMB6, VMB31, and VMB119 
detect similar antigens and were produced in three separate fusions, 
the 30-25 k component(s) may be immunodominant. High antibody activity 
of VMB6 . and VMB31 in ELISA could reflect a greater concentration of 
this antigen in _!:!· bovis and McAb with intermediate activity should be 
considered for future characterization. 
Immunoblot analysis using VMB93 and VMB99 identified antigens of 
M. bovis and of M. tuberculosis, similar findings were obtained in 
ELISA. Existing McAb with specificity to the M. tuberculosis complex25 
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have been used t o isolate corresponding antigens with MW 38 k4128 and 
14 k.7 Detection of a 63 k antigen from M. bovis and a 58 k antigen 
from M. tuberculosis by VMB93/VMB99 identifies an antigenic component 
of M. tuberculosis complex which has not been reported previously. 
Although VMB73 was produced by irrununizing mice with M. bovis and 
hybridoma production, VMB73 exhibited greater binding activity, in 
ELISA, to M. tuberculosis than to ~· bovis , indicating a higher 
concentration of corresponding epitope in M. tuberculosis. Cr oss 
reactivity of VMB73 was confirmed by irnrnunoblot analysis. Multiple 
components detected by VMB73 could result from presence of the 
determinant on numerous antigenic components, or by fragmentation of a 
component containing the determinant . Antigen preparations were stored 
at -70 C to minimize protei'n degradation. The cross-reactive 
determinant identified by VMB73 may be r esponsible in part for cross 
reaction due to mycobacteria other than those in the M. tuberculosis 
complex . The antigen detected by VMB73 resembles a previousl y 
described 65 k antigen. 27 The 65 k antigen is co!Tlf(X)n to numerous 
mycobacteria and other bacteria including N. asteroides . 27 Irrununoblots 
using McAb that detect multiple band patterns may result from 
proteolytic degradation of the 65 k protein antigen . 27 
Each of the six McAb were tested in ELISA to evaluate binding to 
18 field isolates of M. bovis and reference strains AN- 5 and M. bovis 
so:; strain Pasteur. Unexpectedly, some McAb did not exhibit binding 
activity t o some of the M. bovis field isolates tested and the six McAb 
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could again be grouped based on three different types of ELISA 
reactions. VMB6, VMB31, and VMB119 had binding activity to M. bovis 
field isolates but not to strains AN-5 and BCG Pasteur, VMB93 and VMB99 
detected antigen in some isolates but not in strains AN-5 and BCG 
Pasteur, and VMB73 exhibited minimal binding activity to some field 
isolates, similar to VMB93 and VMB99, and BCG Pasteur but not t o strain 
AN-5 . Monoclonal antibody MB514 produced against a virulent field 
isolate of M. bovis detected a 29 .8 k antigen in 44 field isolates of 
M. bovis and in strains Vallee and AN- 5 but not in M. bovis BCG strain 
Glaxo. Monoclonal antibody MB5 may be similar to VMB6, VMB31, and 
VMB119. Failure of VMB93 and VMB99 to detect antigen in M. bovis field 
isolates tested may reflect variation of antigen comt::esition in 
isolates of M. bovis or t::essibly differences in antigen availability in 
assay conditions. The determinant of the M. tuberculosis complex 
detected by VMB93 and VMB99 may be present in low amounts or absent in 
some M. bovis isolates. Failure to exhibit binding activity to M. 
bovis strain AN- 5 is of practical imt::ertance considering use of this 
strain in PPD production. The cross reactive McAb TB23, TB68, TB77, 
TB78 , ML30, and ML34 were used in a radioirranunoassay in attempt t o 
differentiate between M. bovis isolated from cattle and badgers. 13 
These McAb detected each of 22 M. bovis isolates from both cattle and 
badgers, except TB23 which failed to detect one isolate, but failed to 
detect strain AN- 5 when grown on Sautons medium. Differences in OD 
values between McAb detecting similar antigenic comt::enents could result 
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from variation in McAb binding avidity. The variat ion in detecting 
antigens in isolates of !:!· bovis by VMB93/ VMB99 and VMB73 was not 
associated with geographic location or the animal of origin. 
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Table Al . Optical dens ity values of enzyme-linked immunosorbent 
assay for supernatants from fusion 01 
Time (minutes) 
Cell 
Line 
5 10 20 30 40 60 
Negative control 0 . 058 0 .075 0 . 099 0 . 112 0 . 120 0 .117 
1 0 . 668 0 . 773 1.081 1.234 1.237 1.166 
2 0 . 122 0 .119 0 . 165 0 .199 0 . 205 0 . 203 
3 0 . 066 0 . 070 0 .107 0.141 0 . 148 0 . 146 
4 0 . 068 0 .132 0 .137 0 .170 0 .177 0 .175 
5 0.113 0 . 146 0.219 0 . 253 0 . 270 0 . 272 
6 0 . 227 0 . 300 0 . 512 0 . 657 0 . 690 0 . 698 
7 0 .105 0.125 0.184 0 . 226 0 . 239 0 . 233 
8 0 . 090 0 . 107 0 . 159 0 .190 0 . 201 0 .203 
9 0 .111 0 . 122 0 .174 0 . 210 0 . 219 0.218 
10 0 .112 0 . 122 0 . 157 0 . 194 0 . 205 0.203 
11 0 . 061 0 . 082 0 .111 0 .148 0.155 0 .152 
12 0 . 111 0. 153 0.232 0 . 275 0 . 298 0 . 302 
13 0.088 0.115 0.147 0. 178 0 .186 0 .189 
14 0 . 083 0 .101 0 . 127 0 . 161 0 . 169 0.170 
15 0 . 097 0 . 096 0 . 116 0 .150 0 . 157 0.158 
16 0.066 0 . 082 0.105 0 . 140 0 . 149 0 .150 
17 0 . 064 0 . 083 0 . 101 0 .133 0 . 140 0 . 139 
18 0 . 074 0 . 092 0 .1 25 0 .169 0 . 180 0 . 181 
19 0 . 055 0 . 065 0 . 091 0 .123 0 . 130 0 . 128 
20 0 .120 0 .185 0.328 0 .409 0 . 434 0 .442 
21 0.076 0 . 107 0 .166 0 . 206 0 . 222 0 . 222 
22 0 .105 0 . 175 0 . 265 0 . 339 0 . 360 0 . 361 
23 0 .104 0 .142 0 . 243 0 . 319 0 . 342 0 . 351 
24 0 .105 0 .143 0 . 197 0.237 0 . 252 0 . 253 
25 0 . 104 0 . 146 0 . 219 0 . 278 0 . 299 0 . 302 
26 0 . 123 0.161 0 . 225 0 . 292 0 . 312 0 . 315 
negative control 0.140 0 . 225 0.377 0 . 489 0 . 574 0 . 642 
27 0 . 203 0 . 351 0.760 0 . 996 1 . 207 1 . 382 
28 0 . 216 0 . 380 0 . 760 0 . 964 1.157 1.329 
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Table A2 . Optical density values of enzyme-linked iITUnunosorbent 
assay for supernatants from fusion 02 
Time (minutes) 
Cell 
Li ne 
10 30 60 
Negative Control 0 . 031 0 . 067 0 .104 
1 0.678 1.427 2 . 000 
2 0.559 1.182 1 . 697 
3 0 . 061 0 . 144 0 .235 
4 0 . 078 0 . 187 0.301 
5 0 .125 0 . 171 0 . 224 
6 0 .116 0.255 0.440 
7 0 .129 0.250 0 .401 
8 0 . 129 0.284 0 . 487 
9 0 .115 0.236 0 . 359 
10 0.090 0.171 0.265 
11 0.121 0.282 0 .440 
12 0 . 087 0 . 202 0 . 323 
13 0 . 146 0 . 243 0.357 
14 0.217 0.482 0.725 
15 0.128 0 . 293 0.474 
16 0 .067 0 .154 0 .245 
17 0 . 068 0 .159 0 . 249 
18 0 .150 0.339 0 . 544 
19 0 . 098 0.233 0 . 377 
20 0 . 048 0 .113 0 . 179 
21 0 .165 0.244 0 . 336 
22 0 . 218 0 . 525 0 . 859 
23 0.190 0 . 382 0 . 615 
24 0 .173 0 . 393 0 .595 
25 0.220 0.511 0 .813 
26 0 . 101 0.179 0 . 252 
27 0 . 525 1.251 1.799 
28 0.163 0 . 356 0 . 560 
29 0.137 0.181 0 . 214 
30 0 . 038 0 .090 0 .132 
31 0.674 1.438 1.925 
32 0.070 0.164 0 . 257 
Positive Control 1 0 . 533 1.307 1.990 
Positive Control 6 0 . 624 1. 261 1. 764 
Negative Control 0 . 078 0 .087 0 .113 
33 0.131 0.155 0 . 212 
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Table A2 . (Continued ) 
Time (minutes) 
Cell 
Line 
10 30 60 
34 0 .423 1.063 1 . 604 
35 0 . 088 0.123 0 .185 
36 0 .182 0 . 350 0.563 
37 0 . 217 0 .438 0 .686 
38 0 . 085 0.124 0 .178 
39 0 . 097 0 .166 0 . 266 
40 0 . 029 0 . 069 0 . 116 
41 0.131 0 .150 0. 187 
42 0 . 035 0 . 066 0 . 112 
43 0 . 050 0 .118 0 . 196 
44 0 . 064 0. 142 0 . 230 
45 0 . 040 0 . 099 0 . 163 
46 0 . 080 0 .191 0 . 302 
47 0 . 091 0 . 217 0 .331 
Positive Control 1 0 . 633 1.352 1.782 
Positive Control 6 0.667 1.353 1.813 
Negative Control 0 . 054 0 . 066 0 . 078 
48 0 . 002 0 . 023 0 . 042 
49 0 . 493 1 . 040 1 .405 
50 0 . 022 0.062 0 . 095 
51 0 .118 0 .153 0 . 182 
52 0 . 046 0 . 075 0 . 098 
53 0 . 061 0 .108 0.151 
54 0 . 056 0 . 090 0 .112 
55 0 . 061 0 .091 0 .110 
56 0 . 057 0 . 177 0 . 112 
57 0 . 072 0 . 136 0 .188 
58 0 .196 0 . 513 0 . 739 
59 0 .119 0.164 0.19 2 
60 0 .210 0 .508 0 .678 
61 0 .126 0.339 0 .493 
62 0 . 088 0.228 0 .329 
63 0. 141 0 . 366 0 . 516 
64 0 . 130 0 . 340 0 . 489 
Postive Control 6 0 . 245 0 . 628 0 .851 
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Table A3. Optical density values of supernatants for heterologous 
enzyme-linked immunosorbent assaya 
Monoclonal Antibodies 
Species 
tlC VMB6 VMB31 VMB73 VMB93 VMB99 VMB119 
M. bovis 0 .170 0 . 835 
M. tuberculosis 0.142 0 . 283 
M. av1um serovar 1 0.195 0 .112 
M. av1wn serovar 2 0 . 155 0 .150 
M. av1um serovar 4 0.190 0.057 
M. aviwn serovar 8 0.184 0.130 
M. av1wn serovar 10 0 . 239 0 . 240 
M. chelonei 0 . 252 0 .125 
M. fortu1twn 0 . 333 0 . 450 
M. kansas11 0.301 0 . 380 
M. paratuberculos is 0.093 0 . 099 
M. phlei 0.157 0 . 034 
M. scrofulaceum 0.149 0.061 
M. smegmat1s 0 . 362 0 . 439 
N. asteroides 0.210 0.147 
R. equi 0.139 0 . 066 
1.058 
0 . 103 
0 . 066 
0.113 
0 . 075 
0 .129 
0 . 121 
0 . 126 
0 . 317 
0 . 227 
0 . 121 
0.055 
0.068 
0 . 391 
0 . 230 
0 . 065 
0.431 1.096 
1.200 0 . 360 
0.363 0 .148 
0 . 212 0 . 091 
0 .144 0.077 
0 . 036 0 . 044 
0 .511 0.142 
0 .344 0 .133 
1.328 0 . 456 
1.312 0 . 235 
0.259 0 . 073 
0 . 456 0 . 236 
0 . 205 0 . 123 
0.924 0 . 391 
0 . 988 0 . 147 
0 . 288 0.056 
1.109 
0 . 454 
0.092 
0 . 117 
0 . 092 
0 .107 
0 .132 
0.097 
0.289 
0 . 166 
0 . 127 
0 . 068 
0 . 116 
0 . 372 
0 . 178 
0 . 074 
a 
Average of six evaluations using antigen of M. bovis and 
an average of evaluations using antigen of other species. 
1 . 037 
0 .300 
0 . 248 
0.175 
0 . 080 
0 . 130 
0 . 075 
0. 120 
0 .466 
0 .391 
0 .140 
0 . 062 
0 . 133 
0 . 512 
0 .240 
0.083 
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Table A4 . Optical density values of enzyme-linked immunosorbent 
assay using monoclonal antibodies and 18 field isolates of 
Mycobacterium bovis and three reference strains 
Monoclonal Antibody 
M. bovis 
Negative Control VMB6 VMB31 VMB73 VMB93 VMB99 VMB119 
ATCC 19210 0.170 0.835 1.058 0 .431 1.096 1.109 1 . 037 
#1 0 .170 1.174 1. 436 0 . 595 0 .837 0 . 978 1.468 
#2 0 . 063 0 . 505 0 . 534 0 . 236 0 .156 0 . 190 0 .818 
#3 0.170 0 .836 1. 242 0.359 0 . 226 0 . 142 1.217 
#4 0.170 0 . 986 1.379 0 .515 0 .287 0 .387 1 . 382 
#5 0 . 170 1 . 091 0 . 930 0.224 0 .162 0.224 1.027 
#6 0 .170 0 . 616 0 . 851 0.199 0 . 109 0 . 105 0 . 890 
#7 0 .170 1.392 1.680 0 . 492 1 .238 1.674 1 . 343 
#8 0 .170 1.329 1.562 0.375 0 . 646 0 . 822 1.325 
#9 0.170 0 . 957 1.478 0 . 445 0 . 126 0 . 131 1 . 141 
Ul 0 . 170 0.650 0.863 0 . 317 0 .110 0 . 118 0.659 
#12 0 .170 1.214 1.429 0 .450 1.205 1.392 1.125 
#13 0.170 0.481 0 . 668 0.186 0.068 0.108 0.410 
#14 0 .170 o. 716 1.085 0 . 296 0 .117 0.150 0.918 
us 0.170 0 . 465 0 . 585 - 0.219 0 . 017 0.125 0 . 706 
#17 0 .165 0 .887 0 . 908 0 . 353 0 .288 0 . 357 1.176 
#19 0.313 1 . 245 1.248 0 . 802 0 . 957 1.197 1 . 382 
#20 0 . 179 0 .854 0 .873 0 . 441 0 . 673 1 . 076 1 . 227 
#21 0 . 093 0 . 735 0 . 760 0 . 228 0 .497 0 . 664 0 .857 
AN-5 0 . 140 0 .155 0 . 042 0.204 0 .173 0 . 163 0 . 136 
Pasteur 0 .190 0.175 0 . 079 0 . 370 0 . 209 0 .247 0 .281 
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